Podcasts about eci

Federal authorities arrested 13 alleged members of two rival groups engaged in a violent power struggle in the San Fernando Valley for three years. These groups faced charges including attempted murder and illegal firearm possession, and specifically targeted Amazon, posing as carriers on the platform to steal shipments. Market conditions have led to the bankruptcy filing of a Wisconsin carrier, Elite Carriers, and its associated brokerage, ECI, Inc.. Three other businesses owned by the same person also filed for Chapter 11 protection, with both Elite Carriers and ECI reporting between $1 million and $10 million in assets and liabilities. Additionally, US law enforcement has obtained a temporary restraining order against two logistics companies, YDH Express Inc. and YDH International, stopping them from using the US Postal Service with counterfeit postage labels. The companies are accused of shipping thousands of parcels for Chinese customers with fake labels, and the complaint seeks to immediately stop the companies and collect money for financial losses incurred by the postal service. Looking ahead, tune into FreightWaves TV for new episodes of Freightonomics and The Long Haul today. You can also find recaps of the recent Domestic Supply Chain Summit on the YouTube channel and register for the Freight AI Symposium in Washington DC on July 30th, with a ticket special available through Memorial Day weekend. Learn more about your ad choices. Visit megaphone.fm/adchoices

Federal authorities arrested 13 alleged members of two rival groups engaged in a violent power struggle in the San Fernando Valley for three years. These groups faced charges including attempted murder and illegal firearm possession, and specifically targeted Amazon, posing as carriers on the platform to steal shipments. Market conditions have led to the bankruptcy filing of a Wisconsin carrier, Elite Carriers, and its associated brokerage, ECI, Inc.. Three other businesses owned by the same person also filed for Chapter 11 protection, with both Elite Carriers and ECI reporting between $1 million and $10 million in assets and liabilities. Additionally, US law enforcement has obtained a temporary restraining order against two logistics companies, YDH Express Inc. and YDH International, stopping them from using the US Postal Service with counterfeit postage labels. The companies are accused of shipping thousands of parcels for Chinese customers with fake labels, and the complaint seeks to immediately stop the companies and collect money for financial losses incurred by the postal service. Looking ahead, tune into FreightWaves TV for new episodes of Freightonomics and The Long Haul today. You can also find recaps of the recent Domestic Supply Chain Summit on the YouTube channel and register for the Freight AI Symposium in Washington DC on July 30th, with a ticket special available through Memorial Day weekend. Learn more about your ad choices. Visit megaphone.fm/adchoices

Denise is a paediatric physiotherapist who works as a Early Childhood Intervention Consultant and Director of Postural Care Australia. She is Chair of Professionals and Researchers in Early Childhood Intervention (PRECI). Denise has worked in the field of paediatrics,disability and ECI for over 35 years. In the early 2000's Denise led a project changing the WA State Government Disability Services Commission ECI model to a key worker (Team around the Child) model. Denise was a Consultant on the Commission's Statewide Consultancy Team supporting the implementation of recommended practices in ECI and paediatric physiotherapy throughout WA including remote / very remote regions. Denise is a founding member and current chair of PRECI and the PRECI Project lead for the development of the National Best Practice Framework in Early Childhood Intervention in Australia.  This Framework is cross-sector, cross-discipline, cross-diagnosis and cross-service delivery model. To support families with their journey in ECI, Denise was involved in a video series titled ‘Your child, your family and early childhood intervention: Family Perspectives (https://youtu.be/DbuV4isNLDI) translated into 5 different languages, and guides supporting understanding of the national guidelines titled ‘Working Together, therapy in the early years', (2019). Denise is passionate about supporting families and therapists to understand the importance of 24 hour postural care, with a particular focus on supported lying.

דוברים:שלומי קופמן, סמנכ"ל ומנהל החטיבה הבינלאומית.מיכל ברוורמן בלומנשטיק, מנכ”לית מיקרוסופט ישראל מחקר ופיתוח, סגנית נשיא תאגידית בחברת מיקרוסופט העולמית ו-CTO בחטיבת Microsoft Security.מייקי אוסטר, מנכ"ל saffrontech"חדשנות על הבר" היא סדרה מיוחדת במסגרתה מובילי עולם הכלכלה והחדשנות הישראלית מרואיינים על ידי בכירי רשות החדשנות.במפגש הזה נדבר על תהליכי גלובליזציה והפיכת ישראל לשחקן משמעותי בשוק הטכנולוגיה העולמית, ונשמע איך מייקרוסופט פועלת בישראל וכיצד היא משתלבת בשוק המקומי? איך קהילת ההייטק המקומית מצליחה להישאר רלוונטית על אף תחרות קשה בעולם? אילו אסטרטגיות צריכות ליישם חברות טכנולוגיה גדולות בשוק מקומי בכדי לשמור על חדשנות ורלוונטיות ברמה הגלובלית? ומה הצפי של ברוורמן לעתיד ענף ההייטק בארץ?את מי תפגשו על הבר הפעם?מיכל ברוורמן בלומנשטיק, מנכ”ל מיקרוסופט ישראל מחקר ופיתוח, סגנית נשיא תאגידית בחברת מיקרוסופט העולמית ו-CTO בחטיבת Microsoft Security. ברוורמן בלומנשטיק, היא מהנשים הבכירות בענף הסייבר, והיא הובילה את פיתוחם של מוצרים מובילים כמו Sentinel ו-Defender for Cloud. תחת הובלתה, מרכז המחקר והפיתוח של מיקרוסופט בישראל הכפיל את גודלו והפך למוקד חדשנות עולמי בתחום הסייבר וה-AI. מיכל, בעלת תואר שני במדעי המחשב מאוניברסיטת קולומביה, והיא נבחרה לאחת הנשים המשפיעות בישראל על ידי פורבס וגלובס.שלומי קופמן, סמנכ”ל ומנהל החטיבה הבין-לאומית. לקופמן תואר ראשון בלימודי יחסים בינלאומיים ומזרח אסיה מהאוניברסיטה העברית, ותואר שני במנהל עסקים מטעם אוניברסיטת וובסטר. קופמן, בעל 25 שנות קריירה דיפלומטית, התחיל את דרכו המקצועית במגוון תפקידים במשרד החוץ, במסגרתם הוצב בשנחאי כסגן הקונסול, מזכיר מדיני (ראש לשכת השגריר) בוושינגטון, כקונסול מדיני בניו-יורק וכקונסול הכללי בסן פרנסיסקו. עוד שימש קופמן כיועץ מדיני לשר התשתיות הלאומיות ולסגן שר החוץ, וכן עבד במספר חברות בענף ההייטק והטכנולוגיה כמו ECI ואורבוט. בתפקידו ברשות החדשנות, קופמן אחראי על קידום שיתוף הפעולה הבינלאומי עם חברות המבקשות לבצע מו”פ משותף עם חברות ישראליות, מול סוכנויות ביצוע בחו”ל, עם מכוני מחקר, בתי חולים ואוניברסיטאות תוך סיוע וקידום תעשיית ההייטק הישראלית.השנה יסתיים כל מפגש עם במה למייסד או מנכ”ל של סטארטאפ מ”עוטף ישראל”, לשיחה על המוצר וחדשנותו הטכנולוגית, לצד אתגרי השנה וחצי האחרונות מאז ה-7.10 וההזדמנויות קדימה. והפעם- צ'ייסר לסיום עם מייקי אוסטר, מנכ”ל saffrontech. זעפרן- טק שמרכז המחקר והפיתוח שלה ממוקם במושב מבקיעים שליד אשקלון,  עוסקת בגידול indoor של זעפרן. לפני המלחמה התמקדה החברה באוטומציות של שלבי הגידול וחוותה אתגרים. לאחר ה 7.10 התמודדה החברה עם פיילוטים שהיו בעוטף עזה (גני טל), שדרשו הערכות מיוחדת של ספקיה, על מנת להיכנס פנימה והחוצה לאתר, דבר שכמובן לא היה אפשרי. תחילת המלחמה הולידה צורך בשינוי של תכניות ועיכוב, לצד ניהול סיכונים וצמיחה.(*) ללינקדאין שלי: ⁠⁠⁠⁠https://www.linkedin.com/in/guykatsovich/⁠⁠⁠⁠(*) לאינסטגרם שלי: https://www.instagram.com/guykatsovich/(*) עקבו אחרינו ב"עוד פודקאסט לסטארטאפים":ספוטיפיי:https://open.spotify.com/show/0dTqS27ynvNmMnA5x4ObKQאפל פודקאסט:https://podcasts.apple.com/podcast/id1252035397

US President Trump said he is going to make a fair deal with China on trade; predicts that China will eat the tariffs.APAC stocks failed to sustain the positive handover from Wall St and traded mixed; Chinese official PMIs disappointed.European equity futures indicate a contained cash market open with Euro Stoxx 50 future flat after the cash market closed with losses of 0.2% on Tuesday.DXY is a touch higher and building on yesterday's slight gains, EUR/USD is back on a 1.13 handle, AUD leads post-CPI.Looking ahead, highlights include French GDP, German Import Prices, Retail Sales, Unemployment Rate, GDP, CPI, Italian GDP, CPI, EZ GDP, US ADP, GDP, PCE (Q1 & for March), ECI, BoC Minutes, BoE's Lombardelli, Supply from UK, Germany & US.Earnings from Microsoft, Meta, Robinhood, Qualcomm, Albemarle, eBay, Humana, Caterpillar, International Paper, GE Healthcare, Hess, Airbus, Credit Agricole, TotalEnergies, SocGen, UBS, DHL, Kion, Volkswagen, Mercedes Benz, Barclays, GSK, Segro & Glencore.Read the full report covering Equities, Forex, Fixed Income, Commodites and more on Newsquawk

US President Trump said he is going to make a fair deal with China on trade; predicts that China will eat the tariffs.Stocks trade tentatively ahead of a slew of key risk events, including US GDP/PCE and earnings from Microsoft & Meta.USD looks to build on Tuesday's advances, EUR overlooks strong GDP, AUD is supported by hot CPI.USTs are contained into data & refunding, EGBs firmer but largely unaffected by a data deluge.Subdued trade across industrial commodities amid uncertainty and overall downbeat Chinese PMIs.Looking ahead, US ADP, GDP, PCE (Q1 & for March), ECI, BoC Minutes, Comments from BoE's Lombardelli, US Quarterly Refunding.Earnings from, Microsoft, Meta, Robinhood, Qualcomm, Albemarle, eBay, Humana, Caterpillar, International Paper, GE Healthcare, Hess.Read the full report covering Equities, Forex, Fixed Income, Commodites and more on Newsquawk

This week in ERP news, Infor had an exciting week with the general availability of Infor Velocity Suite, enabling a complete offering of solutions and services to simplify process innovation. Sage reinforced its dedication to serving the needs of the healthcare market through continued, collaborative product investment with partner Wipfli. Finally, ECI announced the acquisition of Davisware LLC, a provider of all-in-one business management solutions built for field service organizations.Connect with us!https://www.erpadvisorsgroup.com866-499-8550LinkedIn:https://www.linkedin.com/company/erp-advisors-groupTwitter:https://twitter.com/erpadvisorsgrpFacebook:https://www.facebook.com/erpadvisorsInstagram:https://www.instagram.com/erpadvisorsgroupPinterest:https://www.pinterest.com/erpadvisorsgroupMedium:https://medium.com/@erpadvisorsgroup

Dr. ANA MARIA SERRANO - Associate Professor - Institute of Education (IE), researcher at the Center for Research in Child Studies (CIEC), University of Minho, Portugal.  Has a degree in Psychology from the University of Coimbra. Holds a master's degree in Early Intervention from the University of Cincinnati, USA, as a Fulbright Scholar, and a PhD in Child Studies, a Special Education specialty from the Institute for Child Studies at the University of Minho. She is a professor in the field of Special Education and developed and coordinates one of the first master's programs in Early Childhood Intervention in Portugal (1996). She is member of the National Association for Early Intervention (ANIP), President of the European Association for Early Intervention –EURLYAID, and a member of the Board of Directors of the International Society of Early Childhood Intervention. And she is part of the National System of Early Childhood Intervention (SNIPI), North Subcommittee's Supervision Nucleus. Lives in a city in the North of Portugal – Braga. https://www.eurlyaid.eu/ https://www.eurlyaid.eu/eciguidebook/ https://www.eurlyaid.eu/wp-content/uploads/2023/07/resources-in-ECI.pdf

It's Wednesday, March 19th, 2025. This is Nelson John, let's get started.  ECI to Link Voter IDs with Aadhaar Amid Concerns The Election Commission of India (ECI) will consult UIDAI to link voter IDs (EPIC) with Aadhaar for those who voluntarily provided it. This move aims to eliminate duplicate registrations while adhering to legal provisions. With 66.23 crore voters already sharing Aadhaar details, the plan faces opposition, particularly from the Trinamool Congress, over concerns of duplicate EPIC numbers. The ECI admitted to some errors in assigning codes but clarified that demographic and polling details remain unique. With 99.2 crore registered voters, upcoming discussions will determine how Aadhaar integration can enhance electoral roll accuracy while maintaining privacy and voluntary participation. Trent's Stock Stumbles as Zudio Growth Slows Trent Ltd., which saw a 935% stock surge post-pandemic, is now the worst-performing Nifty 50 stock in 2025, down 26%. The slowdown is tied to Zudio's lagging expansion, as store additions fall below expectations. Growing competition in budget fashion and slower Westside expansion—due to a shift toward larger stores—are also weighing on growth. Analysts, however, remain optimistic about Trent's long-term prospects, citing its strong private labels and diversification into beauty and lab-grown diamonds. But for now, Zudio's future will dictate Trent's stock movement. Bajaj Group to Buy Allianz's Stake for ₹24,180 Crore Bajaj Group is set to acquire Allianz SE's 26% stake in Bajaj Allianz General and Bajaj Allianz Life Insurance, valuing both businesses at ₹93,000 crore. While Bajaj gains full control, analysts predict a future public listing of the insurance arms. Despite high solvency ratios—300% for general insurance and 369% for life insurance—the deal's valuation raises questions. The general insurance acquisition came at a 16% discount compared to ICICI Lombard, but the life insurance buyout appears costly, with weaker profitability. Investors remain cautious as Bajaj's exposure to lending via Bajaj Finance and Bajaj Housing Finance could impact sentiment. The real challenge lies in delivering future earnings growth. Sebi's Settlement Process Under Fire for Delays & High Costs Sebi's settlement mechanism, meant to fast-track securities law violations, is under scrutiny for delays and steep penalties. In FY25, settlements collected ₹851 crore—nearly seven times the ₹125 crore from FY23. Even excluding a ₹643-crore NSE case, the jump is substantial. Yet, efficiency is lagging, with pending settlement cases doubling from 137 in FY23 to 289 in FY24. Critics argue that Sebi arbitrarily inflates settlement amounts and imposes strict non-monetary penalties like voluntary debarments. While Sebi is working on standard operating procedures, legal experts say companies facing delays have little recourse beyond filing writ petitions—though courts rarely intervene. India's Motorcycle Parts Exports Surge, Imports Decline India's motorcycle parts exports have jumped 27% over three years, from $558 million in FY22 to $709 million in FY25, driven by the Production-Linked Incentive (PLI) scheme. Imports, meanwhile, dropped from $408 million to $371 million, reflecting growing self-reliance. The sector is benefiting from deeper integration into global supply chains, with strong demand from Latin America, Africa, and Southeast Asia. In FY24, exports hit $741 million, reversing a dip in FY23. Imports have fallen over 30% in two years, highlighting India's shift toward domestic production. With key buyers like the US, Turkey, and Mexico, India is cementing its place as a global manufacturing hub.

It's a new year and a new administration. Listen to two experts talk about what their crystal balls reveal about the profession's future and how #Ethics and #Compliance professionals should prepare for what may lie ahead.

In this episode of BioTalk Unzipped, hosts Gregory Austin and Chad Briscoe continue their conversation with Dr. Nathan Teuscher, a seasoned expert in clinical pharmacology and pharmacometrics. They discuss the challenges and opportunities presented by new technologies, particularly in drug development and patient engagement. The conversation highlights the evolution of pharmaceuticals, and the potential of virtual clinical trials. In this conversation, Nathan Teuscher discusses the importance of optimizing drug dosages in oncology, the challenges faced in cell therapy, and the complexities of treating immunocompromised patients. He emphasizes the need for collaboration in the scientific community and shares his perspective on measuring success in life and career. Additionally, Nathan talks about his podcast, Clinical Pharmacology (https://creators.spotify.com/pod/show/clinical-pharmacology), which aims to educate listeners on clinical pharmacology and related topics. Chapters 00:51 The Changing Landscape of Pharmaceuticals 03:49 Virtual Clinical Trials and Patient Engagement 08:06 Optimizing Drug Dosage in Oncology 10:55 New News! - FDA Approvals (Mesoblast) and Challenges in Cell Therapy 14:26 The Complexities of Cell Therapy 17:33 Navigating Immunocompromised States in Treatment 20:09 Advice to Young Scientists in Biopharma  23:04 Defining Success in Life and Career 24:47 The Purpose and Impact of Nathan's Podcast, Clinical Pharmacology HOW TO REACH US: Nathan Teuscher https://www.linkedin.com/in/nathanteuscher/  Aplos Analytics - https://aplosanalytics.com/  Email: nathan@aplosanalytics.com Nathan Teuscher's Podcast: Clinical Pharmacology Podcast https://teuschersolutions.com/  Collaboration with BioTalk Unzipped (Ep. 40) https://podcasts.apple.com/us/podcast/collaboration-with-biotalk-unzipped-ep-40/id1695617234?i=1000682122951  Podcast (on Spotify): https://creators.spotify.com/pod/show/clinical-pharmacology Podcast (on Apple): https://podcasts.apple.com/us/podcast/clinical-pharmacology-podcast-with-nathan-teuscher/id1695617234 Dr. Chad Briscoe https://www.linkedin.com/in/chadbriscoe/  Celerion - https://www.celerion.com/   Gregory Austin https://www.linkedin.com/in/gregoryaustin1/  ECI - https://eci-rx.com /  Takeaways Nathan Teuscher has over 20 years of experience in clinical pharmacology and pharmacometrics. Virtual clinical trials can enhance patient engagement and diversity in research. Finding the right dosage is a critical challenge in drug development. Project Optimus aims to redefine oncology drug development practices. AI and data analysis can help identify ideal candidates for clinical trials. Ethical considerations are paramount in the use of patient data for research. The right dose for each patient varies significantly. Understanding individual immune system capacities is crucial in treatment. Collaboration is key to success in the scientific community. Success is measured by the happiness of loved ones. Finding joy in helping others is essential for career fulfillment. Podcasts serve as valuable educational resources. Engaging with diverse disciplines enhances scientific understanding. Sound Bites “If you want to be successful, seek first to understand, then be understood.” “If you're looking to help people and in collaboration, you'll be successful.” “Success in life is the happiness of loved ones around you.” New News Story:  After two rejections, FDA approves Mesoblast's first-of-its-kind cell therapy https://www.fiercepharma.com/pharma/fda-nod-gvhd-cell-therapy-gives-australian-biotech-mesoblast keywords BioTalk, pharmacology, AI in pharma, drug development, Nathan Teuscher, pharmacometrics, virtual clinical trials, clinical research, pharmaceuticals, virtual trials, healthcare innovation, drug development, patient engagement, medical technology, drug dosage, oncology, FDA approval, cell therapy, immunocompromised, collaboration, success, clinical pharmacology, podcast, healthcare

In this episode of BioTalk Unzipped, hosts Gregory Austin and Chad Briscoe welcome Dr. Nathan Teuscher, a seasoned expert in clinical pharmacology and pharmacometrics. The conversation explores Nathan's career journey, the innovative charity Light the World, and the transformative role of AI in drug development. They discuss the challenges and opportunities presented by AI, particularly in automating data analysis and rethinking traditional reporting methods in the pharmaceutical industry. The episode emphasizes the potential for small companies to leverage cloud-based tools and APIs to enhance efficiency and drive innovation in drug development. In this conversation, the speakers explore the intersection of data analysis, AI tools, and advancements in gene editing with organ transplants. Chapters 00:00 Episode Preview 00:55 Introduction to BioTalk Unzipped 02:06 Charity Spotlight: Light of the World 04:51 Nathan Teuscher's Career Journey 07:34 Differentiating AI Types in Life Science 12:41 Challenges with Large Language Models 15:39 Rethinking Reporting in Pharma 17:56 The Future of AI and Analytics in Pharma? 18:52 Leveraging APIs (Application Programming Interfaces) for Small Companies 23:05 Leveraging Data, AI, and APIs in 3 Dimensions 26:22 NEW NEWS! - Gene Editing Breakthroughs in Medicine How to reach us: Light the World Charity - Church of Jesus Christ Latter Day Saints https://www.churchofjesuschrist.org/comeuntochrist/light-the-world  Nathan Teuscher https://www.linkedin.com/in/nathanteuscher/  Aplos Analytics - https://aplosanalytics.com/  Nathan Teuscher's Podcast: Clinical Pharmacology Podcast https://teuschersolutions.com/  Collaboration with BioTalk Unzipped (Ep. 40) https://podcasts.apple.com/us/podcast/collaboration-with-biotalk-unzipped-ep-40/id1695617234?i=1000682122951  Dr. Chad Briscoe https://www.linkedin.com/in/chadbriscoe/  Celerion - https://www.celerion.com/   Gregory Austin https://www.linkedin.com/in/gregoryaustin1/  ECI - https://eci-rx.com /  Sound Bites "We don't need to write reports anymore." Takeaways Nathan Teuscher has over 20 years of experience in clinical pharmacology and pharmacometrics. Light the World charity offers unique giving machines for donations. AI can automate repetitive tasks in drug development, freeing up human capital for innovation. There are two types of AI: large language models and automated data analysis. Large language models can be unreliable in scientific contexts. Pharmaceutical companies spend significant resources on report writing, which may not add value. Small companies can leverage APIs to access standardized calculations and data analysis. The pharmaceutical industry is often insular, limiting the potential of AI. AI could potentially eliminate the need for extensive written reports in drug development. Collaboration and data sharing are crucial for advancing AI in the pharmaceutical industry. Leveraging data effectively requires combining various data sets and tools. The evolution of AI tools is crucial for navigating new technologies. Gene editing represents a significant breakthrough in organ transplantation. New News Story:  A woman in the US is the third person to receive a gene-edited pig kidney https://www.technologyreview.com/2024/12/17/1108905/a-woman-in-the-us-is-the-third-person-to-receive-a-gene-edited-pig-kidney/ Image Credits Pig Kidney, https://ny1.com/nyc/all-boroughs/news/2023/08/16/pig-kidney-works-in-a-donated-body-for-over-a-month--a-step-toward-animal-human-transplants  Keywords BioTalk, pharmacology, AI in pharma, drug development, pharmacometrics, software development, clinical research, Light the World, charity, data analysis, AI tools, gene editing, kidney transplant, pharmaceuticals, virtual trials, healthcare innovation, drug development, patient engagement, medical technology, drug dosage, oncology, FDA approval, cell therapy, immunocompromised, collaboration, success, clinical pharmacology, podcast, healthcare

Join us as Mike Lyon, Jessie Suggs and Amanda Martin take over OPT for a holiday episode! They cover ECI's Top New Home Sales Tips for 2025, the DYC 2024 Holiday Gift Guide items to check out, and share some important skills to check yourself on as we enter 2025! 

Exploring ECI (Erotic Crystallization Inertia) and The Combination Lock Principle -- two Satanic concepts from "The Devil's Notebook" and their importance to Satanists.   00:00 - Intro 02:02 - About "The Devil's Notebook" and LaVey's other books 05:00 - Why ECI is Satanic 06:48 - Erotic Crystallization Inertia (ECI) 16:28 - Thoughts on ECI 23:30 - Why we have Satanic ritual 24:38 - The human phenomenon of ritual. Example: Wade Boggs. 26:04 - The Third Side to Ritual 28:55 - The Combination Lock Principle 30:08 - A point worth repeating 30:20 - The Combination Lock Principle (continued)  

Dr. Tomas Helikar, a leading researcher in bioinformatics and systems biology, delves into groundbreaking work on developing a personalized immune digital twin, which aims to revolutionize the understanding and treatment of immune-related diseases.  Chapters 00:00 Introduction to BioTalk Unzipped 01:50 Meet Dr. Tomas Helikar 04:34 The Journey into Systems Biology 10:03 Understanding Digital Twins in Immunology 14:19 The Importance of Personalized Medicine 17:20 Digital Twin Research Funding and Its Impact 18:38 The Role of Digital Twins in Disease Management 21:11 Digital Twin Efforts for Organ Transplants 24:05 Computational Challenges in Modeling 26:36 Mathematical Models in Biological Research 28:11 - NEW NEWS! - Twist Joins Absci in AI Antibody Collaboration How to reach us: Tomas Helikar  https://www.linkedin.com/in/tomashelikar/  X - https://x.com/tomashelikar  Dr. Chad Briscoe https://www.linkedin.com/in/chadbriscoe/  Celerion - https://www.celerion.com/   Gregory Austin https://www.linkedin.com/in/gregoryaustin1/  ECI - https://eci-rx.com /  Charity Mentioned: https://saintpeterlincoln.com/school  FOLLOW ► LinkedIn: https://www.linkedin.com/company/biotalk-unzipped Twitter: https://x.com/BiotalkUnzipped Instagram: https://www.instagram.com/biotalkunzipped/  Takeaways Dr. Helikar's research focuses on the immune system's network and disease. Systems biology integrates computer science and biology for better understanding. Digital twins can provide personalized models for immune system analysis. Your digital twin model could tell you how you might respond to a particular disease and if you really need to go to the hospital. The immune digital twin reflects an individual's unique immune baseline. Research funding is crucial for advancing innovative medical technologies. Personalized medicine can improve public health outcomes significantly. Computational power is essential for processing complex biological data. Mathematical models are vital for simulating biological processes. Digital twins can enhance drug discovery and clinical trial efficiency. Sound Bites "The immune system is a network of networks." “Each of our immune system baselines are different.” "We need to build out this multi-scale model." New News Story:  Supplier-Turned-Partner: Twist Joins Absci in AI Antibody Collaboration https://www.genengnews.com/topics/drug-discovery/supplier-turned-partner-twist-joins-absci-in-ai-antibody-collaboration/ Image Credits Signal Transduction, www.scientificanimations.com - http://www.scientificanimations.com/wiki-images/ Computational Model, https://computationstructures.org/notes/models/notes.html  Holland computer center, https://newsroom.unl.edu/announce/cse/16380/90600  https://news.unl.edu/article/husker-football-game-day-information-announced-for-2023 https://hcc.unl.edu/office-locations

Dr. Mark Arnold, a distinguished bioanalytical thought leader with an impressive track record in supporting drug development programs. Mark is the Owner and Principal at Bioanalytical Solution Integration, where he provides strategic counsel on complex bioanalytical assays and regulatory compliance. With over 35  years of experience, including leadership roles at BMS and Labcorp, Mark has become a key figure in the biotech and pharma industries. He is also an AAPS Fellow and a founder of the Global Bioanalysis Consortium.  01:05 - Career Reflections and Contributions to Drug Development 05:28 - Understanding the Integration of Drug Development 09:30 - What Would You Change? Embracing Career Risks in Pharma 11:32 - Navigating Career Paths: Small vs. Large Companies 16:09 - NEW NEWS! - Can Electrical Fields Disrupt Cancer? 23:28 - The Role of AI in Drug Development 31:13 - Encouraging Innovation in a Regulated Industry Follow Mark, Chad and Gregory: Please donate to: Samaritan's Purse https://www.samaritanspurse.org/  Mark Arnold - https://www.linkedin.com/in/markearnoldphd/  Blog - https://bioanalysisandbiomarkers.blogspot.com/    Dr. Chad Briscoe - https://www.linkedin.com/in/chadbriscoe/  Celerion - https://www.celerion.com/   Gregory Austin - https://www.linkedin.com/in/gregoryaustin1/  ECI - https://eci-rx.com /  BioTalk Unzipped on LinkedIn - https://www.linkedin.com/company/biotalk-unzipped/  New News Story:  Novocure wins FDA approval for electric field device in lung cancer https://www.biopharmadive.com/news/novocure-fda-lung-cancer-approval-optune-lua-tumor-treating-field/729997 Two articles on finding 1000's of dark matter RNA viruses:   https://www.fiercebiotech.com/research/deep-learning-ai-model-scans-dark-matter-genomic-data-and-finds-70000-never-seen-rna https://www.nature.com/articles/d41586-024-03320-6 Image Credits Novocure images courtesy of Novocure: www.novocure.com 

In this episode of BioTalk Unzipped, host Gregory Austin and co-host Chad Briscoe engage with Dr. Mark Arnold, a distinguished bioanalytical thought leader. They discuss the impact of recent FDA regulations on drug development, the importance of community support through the Samaritan Purse charity, especially on recent hurricane victims, and the exciting advancements in RNA editing technologies. The conversation highlights the collaborative nature of the pharmaceutical industry and the drive behind bioanalytical work, emphasizing the ultimate goal of delivering effective therapies to patients. Chapters00:00 Introduction to BioTalk Unzipped at AAPS PharmSci 36003:45 Samaritan's Purse Charity and Community Impact05:16 Most impactful talk at AAPS?11:50 Comparative Analysis of FDA and EU Regulations17:37 The Drive Behind Bioanalytical Work22:24 NEW NEWS! - Innovations in RNA Editing and BioanalysisTakeaways​The FDA's new rules on lab-developed tests could delay biomarker utilization in clinical trials.​Community support through charities like Samaritan's Purse is crucial during crises.​The importance of collaboration in advancing drug development and bioanalytical methods.​Innovations in RNA editing present new bioanalytical challenges.​The drive to help patients is a key motivator for professionals in the field.​Sound Bites​"I worked on that drug and there's a clear benefit."​"It's getting that new therapy to a patient."​"This is going to change and potentially delay biomarkers."​New News Story: ​Wave sees RNA editing validation in early trial results◦https://www.biopharmadive.com/news/wave-rna-editing-aatd-first-trial-data/729981/ How to reach us:Please donate to: Samaritan's Pursehttps://www.samaritanspurse.org/ Mark Arnoldhttps://www.linkedin.com/in/markearnoldphd/ Blog - https://bioanalysisandbiomarkers.blogspot.com/  Dr. Chad Briscoehttps://www.linkedin.com/in/chadbriscoe/ Celerion - https://www.celerion.com/  Gregory Austinhttps://www.linkedin.com/in/gregoryaustin1/ ECI - https://eci-rx.com / Image Credits​AAPS

Sijie Wei, Co-CEO of language services, technology, and game localization specialist EC Innovations (ECI), joins SlatorPod to talk about his new role as co-CEO and leading one of Asia's largest LSPs with revenues exceeding USD 50m in 2023.Sijie shares how ECI, initially focused on helping Western blue-chip firms enter China, expanded to assisting Chinese tech giants like Tencent and ByteDance in globalizing their products.Sijie highlighted the challenges of the Asia-Pacific market, where localization maturity still lags that of the US and Europe in certain verticals. However, he sees significant growth potential as industries like e-commerce, AI, and electric vehicles mature. Regarding language AI, Sijie pointed out that Chinese companies prefer to develop their own solutions, making the market highly competitive. ECI benefits from this research, applying cutting-edge advancements in AI to client projects. In game localization, Sijie continues to see substantial growth potential. He recognizes that localizing games from China to global markets and vice versa is equally challenging due to differences in player preferences, monetization methods, and cultural contexts.Sijie gave his insights on the investment landscape, noting that current market valuations are lower due to uncertainty around AI adoption across industries like localization.Sijie concluded by addressing the balance between AI and human expertise in localization, emphasizing that while AI can drive efficiency, human quality remains superior in many contexts.

SAP began the week by announcing major financial results for the third quarter ended September 30th, 2024. Acumatica followed with the long-anticipated launch of its new Professional Services Edition, built to enable small and midsized professional services firms to increase efficiency and accelerate growth. ECI announced the launch of two new add-on solutions for its Manufacturing ERP products – ECI Manufacturing Execution System (MES) and ECI Advanced Planning & Scheduling (APS), both powered by LYNQ. QAD closed its acquisition of Phenix Software Inc. to help manufacturers improve productivity and accelerate factory performance. Finally, IFS unveiled new IFS.ai-powered features being introduced in the IFS Cloud 24R2 focusing on delivering maximum value to asset and service-intensive industries and elevating the user experience to drive industrial AI adoption at scale.Connect with us!https://www.erpadvisorsgroup.com866-499-8550LinkedIn:https://www.linkedin.com/company/erp-advisors-groupTwitter:https://twitter.com/erpadvisorsgrpFacebook:https://www.facebook.com/erpadvisorsInstagram:https://www.instagram.com/erpadvisorsgroupPinterest:https://www.pinterest.com/erpadvisorsgroupMedium:https://medium.com/@erpadvisorsgroup

EP-23. In the second half of this compelling conversation on BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe continue their deep dive with Scott Ogle, CEO of TruLab. They explore the surprising parallels between the banking and pharma industries, the game-changing role of digital twinning in clinical trials, and the biotech funding landscape. Scott also shares his thoughts on leadership, mentorship, and the impact of the Inflation Reduction Act on pharma innovation. This episode offers listeners valuable insights into the future of drug development and the challenges of balancing professional and personal life in a fast-paced industry. Chapters 1:09 - Comparison of the Banking Industry to the Pharma Industry 5:18 - Data Integrity, Same For Decentralized Trials? 8:33 - Biotech Funding Trends 11:18 - NEW NEWS! – Digital Twinning in Clinical Trials 16:15 - What Advice Would You Give to Your Younger Self? 20:57 - Mentorship and Its Impact, How it Shaped Scott 23:45 - Balancing Work and Personal Life 24:32 - The Inflation Reduction Act and Innovation Takeaways The regulatory environment in pharma can slow down innovation. Digital twinning in clinical trials could revolutionize drug development. Family influences play a significant role in shaping business perspectives. The need for a strong company culture to maintain values during growth. Biotech funding trends are influenced by macroeconomic factors like interest rates. The importance of mentorship in professional development. Sound Bites “The similarities between the banking industry and the pharma industry is eerily similar.” “Quality is really what we do.” “Being quality is core to software.” “It's really clear people care more about their money than they do their healthcare.” “Biotech and large pharma seem to balance each other out.” “The career for you is at the intersection of what you are good at and what you like to do.”  “If you're good at something and you like to do it, it fuels your energy to keep getting better.” “Enjoy the impact in what you're doing and accomplishing!” New News Story:  Digital “Twinning”: Clinical Trials Powered by AI https://www.sanofi.com/en/magazine/our-science/digital-twinning-clinical-trials-ai   How to reach us: Scott Ogle https://www.linkedin.com/in/scott-ogle/  TruLab - https://trulab.com/    Dr. Chad Briscoe https://www.linkedin.com/in/chadbriscoe/  Celerion - https://www.celerion.com/   Gregory Austin https://www.linkedin.com/in/gregoryaustin1/  ECI - https://eci-rx.com /  Image Credits Digital Twinning - Credit Getty Images Simulation - Credit: andrush / Adobe Stock Tomáš Helikar - https://www.linkedin.com/in/tomashelikar/  Nebraska Swan computer - https://newsroom.unl.edu/announce/cse/16380/90600 Brian Hamilton - https://inmatestoentrepreneurs.org/board/brian-hamilton/ 

This is the Catch Up on 3 Things by The Indian Express and I'm Flora Swain.Today is the 11th of October and here are the top stories of the week.The results of Haryana and Jammu and Kashmir Assembly polls were declared by the ECI on Tuesday. The ruling BJP secured a historic third term in Haryana, winning 48 Assembly seats. The Congress, meanwhile, won 37 seats, Independents stood at 3 and the INLD won 2 seats. In the JK UT, The NC-Congress alliance crossed the 46-seat majority mark, securing 49 seats . The NC won the highest number of seats at 42, the Congress took six, and the Communist Party of India (Marxist), which was also part of the alliance, secured one. Meanwhile, the BJP won 29 seats and the PDP bagged three. Seven Independents were declared victorious. The AAP and Jammu & Kashmir People Conference secured one seat each.The final rites of Ratan Tata, the legendary industrialist and Chairman Emeritus of Tata Sons, were performed with full state honors on Thursday evening. Tata, 86, breathed his last on Wednesday night at Mumbai's Breach Candy Hospital. Among those who paid respects to the business tycoon are Union Home Minister Amit Shah, Union Minister Piyush Goyal, Maharashtra CM Eknath Shinde, Deputy CM Devendra Fadnavis, Gujarat CM Bhupendra Patel, and industrialist Mukesh Ambani. Maharashtra Chief Minister Eknath Shinde has proposed that a Bharat Ratna be awarded to Tata, posthumously.Setting the stage for a new tussle between the Aam Aadmi Party and the L-G office, the CMO on Wednesday claimed that Chief Minister Atishi was “forcibly vacated” from the residence at Civil Lines, which was previously occupied by Arvind Kejriwal. “Delhi CMs residence was forcibly vacated at the behest of the BJP as Lt Governor V K Saxena wants to allot it to a saffron party leader,” the CMO said. This comes two day after Atishi was asked to vacate the bungalow by officials from the Public Works Department (PWD)- a department under her own charge. The Aam Aadmi Party claims that Atishi followed all formalities before moving in, but the PWD says that an official “handover” of the property from Kejriwal to the department is yet to take place. The house has now been sealed.Maldives President Muhammad Muizzu reached New Delhi Sunday on his first bilateral State visit and was received at the airport by Minister of State (External Affairs) Kirti Vardhan Singh. During his five-day visit — from October 6 to 10 — he travelled to Agra, Mumbai and Bengaluru. Both Modi and Muizzu launched Rupay card in the Maldives, inaugurated the new runway at the Hanimadhoo International airport and agreed to further strengthen bilateral relations that had hit a rocky patch last year.US President Joe Biden and Israeli Prime Minister Benjamin Netanyahu had a call on Wednesday amid tensions with Iran. The 30-minute call was the first known chat for Biden and Netanyahu since August and coincides with a sharp escalation of Israel's conflict with Iran and the Iran-backed Lebanese Hezbollah, but with no sign of an imminent ceasefire to end the conflict with Iran-backed Hamas in Gaza. The call was "direct and very productive," White House press secretary Karine Jean-Pierre told reporters, while acknowledging the two leaders have disagreements and are open about them.This was the Catch Up on 3 Things by The Indian Express.

Summary In this 22nd episode of BioTalk Unzipped, host Gregory Austin and co-host Chad Briscoe engage with Scott Ogle, CEO of TrueLab, discussing his journey from finance to the pharmaceutical industry, the impact of personal experiences on innovation, and the importance of technology in clinical trials. They explore how to hire the best employees in this climate, the significance of company culture, and the influence of family on business perspectives.  Chapters 00:00 Introduction to BioTalk Unzipped 03:15 The Impact of Personal Experience on Innovation 08:47 TruLab's Technology and Its Role in Clinical Trials 14:33 The Importance of Sample Management and the Genesis of TruLab 20:33 NEW NEWS! – The Future of Cancer Treatments 23:34 Hiring Patterns and the value of Company Culture Takeaways Scott Ogle's personal experience with his father's illness inspired the creation of TruLab. TruLab focuses on eliminating inefficiencies in clinical trial sample management. The importance of having fun in one's career for productivity and happiness. Hiring for energy and cultural fit is crucial for company success. More young people out of college actually prefer working in the office, so it's a hiring advantage. Sound Bites “Entrepreneurs get excited about their solution but can forget about what problem they're solving.” "We need to iterate on technology in clinical trials." “20-25% of biological samples get tossed out.” "You can't coach energy in a candidate." “Company values. Senior leadership must beat it like a drum.” “Interviewing candidates on company values is your North Star.” “Go by what people do, not by what they say.”  “Hallway meetings, that's where stuff gets done.” New News Story:  ISB 2001 trispecific T cell engager shows strong tumor cytotoxicity and overcomes immune escape mechanisms of multiple myeloma cells https://www.nature.com/articles/s43018-024-00821-1 How to reach us: Scott Ogle https://www.linkedin.com/in/scott-ogle/  TruLab - https://trulab.com/  Leukemia & Lymphoma Society - https://www.lls.org/    Dr. Chad Briscoe https://www.linkedin.com/in/chadbriscoe/  Celerion - https://www.celerion.com/   Gregory Austin https://www.linkedin.com/in/gregoryaustin1/  ECI - https://eci-rx.com /  Keywords: Scott Ogle, TruLab, clinical trial technology, biotech innovation, sample management in clinical trials, hiring for company culture, company values in leadership, finance to pharma journey, revolutionizing clinical trials, impact of personal experience on innovation, biotechnology leadership, clinical trial inefficiencies, cancer treatment news, digital transformation in pharma, family influence in business, company culture in biotech, pharmaceutical funding challenges, ISB 2001 trispecific T cell engager. Tags: #ScottOgle, #TruLab, #ClinicalTrials, #Biotech, #PharmaInnovation, #Sample Management, #Company Culture, #Hiring Tips, #BiotechLeadership, #PharmaTechnology, #CancerTreatment, #PersonalInnovation, #BiotechFunding, #LeadershipInPharma, #BusinessLeadership, #PharmaceuticalIndustry.

Mentoring in Pharmaceutical Science with Dr. Jim Shen Summary In Episode 21 of BioTalk Unzipped, host Gregory Austin and co-host Dr. Chad Briscoe interview Dr. Jim Shen, the executive director and head of regulated bioanalysis operations at BMS. Jim discusses his early career in bioanalysis and the importance of mentorship. He emphasizes the need to recognize and appreciate the success and expertise of others, as well as the importance of building a network of champions, allies, and sponsors. The conversation also touches on the topic of psychedelics as a drug therapy and the recent retraction of scientific papers on MDMA-assisted therapy. Jim shares his passion for photography, particularly infrared photography, and the resurgence of film photography. Chapters 01:14 - Jim's Favorite Publication and His Journey into Bioanalysis 04:15 - Finding Joy in Your Work: Pursuing Your Interests and Making a Difference  05:10 - Early Career in Bioanalysis 07:35 - The Importance of Mentorship and Dealing With Adversaries 17:35 - NEW NEWS: Retraction of Scientific Papers on Drug Therapy 24:55 - Personal Interests: Photography and Gaming Takeaways Dr. Shen's journey into bioanalysis highlights the importance of pursuing your interests and finding enjoyment in your work, even if it may not align with your initial plans. Building a supportive and collaborative community is crucial in the field of bioanalysis, where knowledge sharing and networking play a significant role in advancing research and innovation. Recognize and appreciate the success and expertise of others Build a network of champions, allies, and sponsors Be open to new career opportunities and emerging fields Maintain integrity and transparency in scientific research Explore different hobbies and interests outside of work Sound Bites “Sponsors are those with the power to change your career. Those people don't come along very often, so you need to really grab them when you see them.” “EQ is so important in being successful in your larger pharmaceutical company.” “I first tell my staff to divide people into 3 groups, champions, allies, and sponsors.” “And it is very hard to be in this field, to be a scientist, but you know, it's the people that make it worthwhile.” New News Story:  Following FDA rejection, a journal retracts papers on MDMA-assisted therapy https://www.biopharmadive.com/news/lykos-journal-mdma-retractions-maps-ptsd-unethical-conduct/723945/  How to reach us: Dr. Jim Shen https://www.linkedin.com/in/jimxshen/  Bristol Myers Squibb - https://www.bms.com/    Dr. Chad Briscoe https://www.linkedin.com/in/chadbriscoe/  Celerion - https://www.celerion.com/   Gregory Austin https://www.linkedin.com/in/gregoryaustin1/  ECI - https://eci-rx.com /  Image Credits Travis Kelce: https://www.google.com/url?sa=i&url=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3DQY8xlVldVp8&psig=AOvVaw2yCKg3oh923dt0beIIR8w3&ust=1726284386832000&source=images&cd=vfe&opi=89978449&ved=0CBcQjhxqFwoTCICN_OD8vogDFQAAAAAdAAAAABB2 https://www.te-university.com/posts https://people.com/travis-kelce-says-hes-his-own-worst-critic-on-the-field-8684839 https://www.marca.com/en/nfl/kansas-city-chiefs/2023/07/12/64aec11a268e3e242d8b458e.html https://www.newheightshow.com/  https://www.aol.com/fans-think-moment-travis-kelce-185629668.html World of Warcraft Guilds https://www.dexerto.com/world-of-warcraft/wow-players-critical-of-unrealistic-guild-expectations-for-season-of-discovery-2392361/  Infrared Photography: Jim Shen Keywords Pharmaceutical, Mentor, Mentorship, Mentoring, Science, Biotech, Biotechnology, Gaming, Photography, Bioanalysis

Workday announced Illuminate, the next generation of Workday AI. Following the Illuminate announcement, Workday announced that it signed a definitive agreement to acquire Evisort, an AI-native document intelligence platform. BlackRock, Global Infrastructure Partners (GIP), Microsoft, and MGX announced the Global Infrastructure Investment Partnership (GAIIP) to make investments in new and expanded data centers to meet growing demand for computing power, as well as energy infrastructure to create new sources of power for these facilities. Blackbaud announced deeper integration of Microsoft AI and analytics into their purpose-built software for unique business operations of social impact organizations – without the need for costly customizations. Salesforce and NVIDIA announced a strategic collaboration to develop advanced AI capabilities for the enterprise with autonomous agent and interactive avatar experiences. ECI announced a new integration of its EvolutionX, its B2B ecommerce platform, with e-automate, its cloud-based business management ERP software.Connect with us!https://www.erpadvisorsgroup.com866-499-8550LinkedIn:https://www.linkedin.com/company/erp-advisors-groupTwitter:https://twitter.com/erpadvisorsgrpFacebook:https://www.facebook.com/erpadvisorsInstagram:https://www.instagram.com/erpadvisorsgroupPinterest:https://www.pinterest.com/erpadvisorsgroupMedium:https://medium.com/@erpadvisorsgroup

NetSuite announced a series of new product updates and AI innovations across the suite to help organizations increase efficiency and accelerate growth. Oracle was busy making major data and AI-related announcements, alongside its new partnership with AWS. Qlik announced new enhancements to its AutoML capabilities. Certinia announced the general availability of Certinia Customer Success (CS) Cloud. ECI announced the completion of its acquisition of Khameleon Software, a cloud-based ERP software company supporting the unique needs of project-based dealers.Connect with us!https://www.erpadvisorsgroup.com866-499-8550LinkedIn:https://www.linkedin.com/company/erp-advisors-groupTwitter:https://twitter.com/erpadvisorsgrpFacebook:https://www.facebook.com/erpadvisorsInstagram:https://www.instagram.com/erpadvisorsgroupPinterest:https://www.pinterest.com/erpadvisorsgroupMedium:https://medium.com/@erpadvisorsgroup

In this episode (EP20) of BioTalk Unzipped, host Gregory Austin and co-host Dr. Chad Briscoe interview Dr. Jim Shen, the Executive Director and Head of Regulated Bioanalysis Operations at BMS. They discuss topics such as the advancements in cancer therapies, the integration of AI and mechanistic modeling in drug development, and the complexities of regulatory submissions. Dr. Shen shares his journey into bioanalysis and his passion for mass spectrometry.  Chapters 01:15 - Introduction, Background, and Passion for The American Cancer Society 03:46 - Advancements in Cancer Therapies, Opdualag  08:03 - From Small Molecule to Large to Hybrid 12:52 - NEW NEWS! - Halda Raises $126M for a New Targeted Cancer Therapy 18:30 - Dr. Shen's Journey from Computers to Chemistry into Bioanalysis 27:00 - The Integration of AI and Mechanistic Modeling in Drug Development 34:30 - Navigating the Complexities of Regulatory Submissions Takeaways Advancements in cancer therapies, such as immunotherapy and antibody drug conjugates, have revolutionized the treatment landscape and improved patient outcomes. The integration of AI and mechanistic modeling in drug development shows promise but is still in its infancy. More research and collaboration between software and hardware engineers are needed to fully realize its potential. Navigating the complexities of regulatory submissions requires adherence to international guidelines and validation of analytical methods to ensure accuracy and precision. Dr. Shen's journey into bioanalysis highlights the importance of pursuing your interests and finding enjoyment in your work, even if it may not align with your initial plans. Sound Bites "Advancements in cancer therapies have revolutionized the treatment landscape." "Antibody drug conjugates are one of the most exciting and interesting types of molecules." "The integration of AI and mechanistic modeling in drug development shows promise but is still in its infancy." New News Story:  Startup Halda raises $126M to advance new type of targeted cancer therapy https://www.biopharmadive.com/news/halda-series-b-riptac-prostate-cancer/723933/ How to reach us: American Cancer Society https://www.cancer.org/  Dr. Jim Shen https://www.linkedin.com/in/jimxshen/  Bristol Myers Squibb - https://www.bms.com/    Dr. Chad Briscoe https://www.linkedin.com/in/chadbriscoe/  Celerion - https://www.celerion.com/   Gregory Austin https://www.linkedin.com/in/gregoryaustin1/  ECI - https://eci-rx.com /  Images ADC Mechanism of Action https://www.researchgate.net/figure/Antibody-drug-conjugate-ADC-structure-and-mechanistic-schematic-Inset-in-upper-right_fig1_364183953  https://www.researchgate.net/figure/General-structure-of-antibody-drug-conjugate_fig1_355319441  Keywords Bioanalysis, Cancer, Oncology, Research, Drug Development, Compliance, Regulatory Compliance, AI, ADC, Antibody Drug Conjugates, immunotherapy, Pharmaceutical, Biotechnology, Podcast, Science, Pharmaceutical Science

Send us a Text Message.Vertical software was once considered a niche market within enterprise software, primarily served by VARs and ISVs with limited growth potential, while OEMs thrived on platform and ecosystem-focused business models. However, this landscape has shifted, especially with private equity firms adopting consolidation strategies during economic downturns, leading to a reevaluation of their go-to-market and marketing approaches and sometimes even overhauling their code bases entirely. This trend has affected even major proponents of platform strategies, like Salesforce, which has acquired vertical capabilities and introduced industry-specific packages. ServiceTitan stands out as one of the top vertical SaaS offerings listed on Forbes Cloud 100, potentially disrupting the ERP market dominated by companies such as Epicor and ECi. When considering Advantive, it can be challenging to determine who is disrupting whose market. But what exactly is ServiceTitan? Is it a field service application? An industry-specific CRM? A channel integration tool tailored for particular sectors, akin to ChannelAdvisor? Or is it a blend of all these functionalities? Could it even qualify as an ERP system?In today's episode, we invited a panel of industry experts for a live discussion on LinkedIn to conduct an independent review of ServiceTitan's capabilities. We covered many grounds, including where ServiceTitan might be a fit in the enterprise architecture and where it might be overused. Finally, they analyze many data points to help understand ServiceTitan's core strengths and weaknesses.For more information on growth strategies for SMBs using ERP and digital transformation, visit our community at wbs. rocks or elevatiq.com. To ensure that you never miss an episode of the WBS podcast, subscribe on your favorite podcasting platform. 

Tim Watkins, VP of Integrated Solutions at ECI, joins Contributing Lead Editor Amy Bryson to discuss how data flow between design and manufacturing, facilitated by an ERP solution, improves collaboration, functionality, customization and customer satisfaction. 

In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe continue their conversation with Zealic CEO, Chuck Piccirillo. They delve into the unique challenges of the patient journey and the increasing demand for hybrid healthcare solutions that offer more flexibility. The discussion highlights the rise of virtual health, particularly in Europe, and introduces exciting developments in ion channels as a goldmine for new medicines. They also explore the financial intricacies of drug development, the importance of leadership through incremental steps, the value of in-person interactions, and hard-earned lessons in the industry. Finally, Chuck offers invaluable advice for entrepreneurs in the life sciences sector. Chapters 00:17 - Adapting to what is unique in the patient journey. 07:08 - Push for hybrid solutions - more flexibility. 09:20 - Virtual health is emerging, especially in Europe. 14:02 - New News! - Ion Channels are a goldmine for new medicines 19:23 - The Financial Side of Drug Development 21:50 - Leadership - Incremental Steps, the Value of In-Person Interactions, Learning Hard Lessons 30:58 - Advice For Entrepreneurs in Life Science Takeaways Building blocks to build the digital patient experience, then tweak it to the individual drug and form a complex digital and personal adaptive health journey. The healthcare industry needs to find a balance between safety and innovation to ensure patients have access to the best possible care. Remote patient monitoring and decentralized clinical trials are crucial in improving patient engagement and outcomes in the healthcare industry. Virtual visits and technology integration can enhance patient engagement and make healthcare more accessible. While there has been an increase in decentralized trials, the focus is currently on commercial solutions due to the crowded nature of the clinical trial technology space. Virtual health and routine monitoring have the potential to alleviate the burden on healthcare providers and improve patient care. Ion channel research holds promise for developing new medicines and treatments for various conditions. Incremental progress and persistence are key in entrepreneurship and leadership. Sound Bites (regarding adaptability in clinical software) “Imagine if LinkedIn only every 6 months. How engaging would that be?” "And it would actually integrate with like Uber, for example, and help them get a ride if they had to go to the doctor and actually, and all of that is based on these building blocks that we're able to assemble and then press a button." “I think everybody wants whatever aspect of life nowadays to be hybrid anything.” “It's why we always talk about pragmatic innovation.” “Persistence in the face of opposition of all sorts.” New News Story:  These microscopic tunnels are a goldmine for new medicines https://www.biopharmadive.com/news/ion-channels-drug-research-vertex-biohaven-jazz/719337/  How to reach us: Crohn's & Colitis Foundation https://www.crohnscolitisfoundation.org/  Chuck Piccirillo https://www.linkedin.com/in/cpiccirillo/  Zealic Health - http://www.zealichealth.com   Dr. Chad Briscoe https://www.linkedin.com/in/chadbriscoe/  Celerion - https://www.celerion.com/   Gregory Austin https://www.linkedin.com/in/gregoryaustin1/  ECI - https://eci-rx.com /  Keywords Patient Journey, Hybrid Healthcare Solutions, Drug Development Finance, Leadership in Life Sciences, Entrepreneurship in Life Sciences, Remote Patient Monitoring, Decentralized Clinical Trials, Healthcare Technology Integration, Digital Patient Experience, Clinical Software Adaptability, Pragmatic Innovation, Persistence in Entrepreneurship, Leadership #HealthcareInnovation #VirtualHealth #DrugDevelopment #LifeSciences #Entrepreneurship #DigitalHealth #HybridHealthcare #IonChannels #PatientCare #RemoteMonitoring #ClinicalTrials #Leadership #HealthTech #PragmaticInnovation #Persistence #pharmaceutical #biotech #science #CEO

Microsoft announced results for the quarter ended June 30, 2024, as compared to the corresponding period of last fiscal year. Blackbaud announced financial results for its second quarter ended June 30, 2024. ECI announced the completion of its acquisition of ProfitKey International LLC, an ERP platform for discrete manufacturers. Salesforce signed a definitive agreement to acquire PredictSpring, a modern retail Point-of-Sale software vendor built natively in the cloud. SAP launched new cloud capabilities for SAP Product Lifecycle Management Solutions through a strategic co-innovation with Hilti AG, a provider of products and services for the construction industry. Acumatica announced the hiring of veteran technology leader, Miten Mehta, as the company's Chief Engineering Officer.Connect with us!https://www.erpadvisorsgroup.com866-499-8550LinkedIn:https://www.linkedin.com/company/erp-advisors-groupTwitter:https://twitter.com/erpadvisorsgrpFacebook:https://www.facebook.com/erpadvisorsInstagram:https://www.instagram.com/erpadvisorsgroupPinterest:https://www.pinterest.com/erpadvisorsgroupMedium:https://medium.com/@erpadvisorsgroup

Summary In this conversation, Gregory Austin and Chad Briscoe interview Chuck Piccirillo, CEO of Zealic Health, about his experience in the healthcare industry and the focus on patient-centric solutions. Chuck shares his personal journey with colitis and how it ultimately inspired him to start Zealic Health. The company aims to provide highly patient-centric digital platforms to improve care and treatment in the healthcare industry. The panel tackles the tough questions around the new LDT as a Medical Device final ruling by the FDA. They then discuss the challenges of navigating regulations and the use of AI in healthcare. Chuck also shares the story of how Zealic Health adapted to the war in Ukraine and relocated their employees to Poland.  Takeaways Zealic Health focuses on providing patient-centric digital platforms to improve care and treatment in the healthcare industry. Navigating regulations and ensuring compliance is a challenge in the healthcare industry, especially with the introduction of new technologies like AI. Zealic Health adapted to the war in Ukraine by relocating their employees to Poland, demonstrating their commitment to their team and their mission. The FDA final ruling is clearly to improve safety but the confusion is in the interpretation of that ruling and  Sound Bites “The biggest challenge is the interpretation of these (LDT) rules.” “Typically I'm not in favor of what Congress is doing.” “Trying to understand how we're going to navigate the space … it's just been confusing.” "The FDA is trying to protect us, but they need to navigate these things and engage industry experts." “(regarding AI) Where does marketing end and reality begin?” "AI isn't going to say, 'We don't need the doctor, just use AI.'" “The people who are out of their jobs won't be the ones using AI. The people who are out of their jobs will be the ones who don't.” “The whole promise of AI is taking massive amounts of data and finding those patterns Chapters 01:33 Introduction and Background 04:03 The Crohn's & Colitis Foundation and Chuck's struggle with Colitis 07:49 Patient-Centric Solutions in Healthcare and Zealic Health 13:26 Plan B - Moving offices from Ukraine to Poland 20:02 New News!! - The Controversy of LDTs Becoming Medical Devices 27:20 Implications of healthcare and regulations as it applies to AI 30:07 AI in Diagnosis - Promises and Pitfalls New News Story: House committee tells FDA to suspend lab developed test rule https://www.healthcaredive.com/news/house-committee-fda-suspend-ldt-rule/721362/  How to reach us: Crohn's & Colitis Foundation https://www.crohnscolitisfoundation.org/  Chuck Piccirillo https://www.linkedin.com/in/cpiccirillo/  Zealic Health - http://www.zealichealth.com   Dr. Chad Briscoe https://www.linkedin.com/in/chadbriscoe/  Celerion - https://www.celerion.com/   Gregory Austin https://www.linkedin.com/in/gregoryaustin1/  ECI - https://eci-rx.com /  Image credits: https://www.crohnscolitisfoundation.org/  LDT/FDA, https://x.com/FDADeviceInfo/status/1784965525522493657  Congress, https://worldstrides.com/blog/2013/07/u-s-capitol/  Cost, https://www.freepik.com/photos/increasing-costs  Cancer patient, https://www.freepik.com/free-photo/sick-asian-man-sitting-chair-side-view_33753979.htm  CAD - Computer Aided Detection, https://researchoutreach.org/articles/assessing-performances-computer-aided-diagnosis-breast-cancer/  #BioTalkUnzipped #Podcast #HealthcareInnovation #PatientCare #AIinHealthcare #FDARegulations #Ukraine #LifeSciences #DigitalHealth #AI #pharmaceutical #biotechnology #medicaldevice

Summary Dr. Andy Vick shares some of the things that surprised him throughout his career and he discusses his passion for reptiles and his experience discussing the pharmaceutical potential of venom with future toxicologists at Ashland University. Next, Andrew Vick discusses his role as an adjunct professor at Ohio State University, his involvement in academia, and how he got into it. We discuss a story about a clinical study that restored hearing in children with gene therapy. The conversation concludes with a discussion about the impact of professional organizations like AAPS on the industry and the importance of networking and fellowship. Takeaways Cancer doesn't have the same death sentence - fear factor it used to have 30+ years ago. It takes about 10 years for a newly discovered compound to make it on the market. Andrew Vick is passionate about reptiles and has a collection of rare reptiles. He enjoys educating others about reptiles and their pharmaceutical potential, particularly venom. There's a shift from small molecules to biologics in the past 5 years. Andrew Vick visited Ashland University to discuss the pharmaceutical potential of venom with future toxicologists, combining his passion for reptiles and pharmaceutical science. Andrew Vick is an adjunct professor at Ohio State University, where he teaches in the College of Pharmacy Division of Pharmaceutical Chemistry. His role as an adjunct professor involves giving guest lectures, providing career and professional development for students, and serving on the Dean's Corporate Council. Andrew Vick is also involved in evaluating assets developed in academia and collaborating with industry to develop strategies for bringing products to the clinic. We discuss a study by Regeneron that used gene therapy to restore hearing in children with mutations in the otoferlin gene. Regarding Cell-Gene Therapy we have a lot to learn both from the positive pharmacological potential, but also from a safety and tolerability standpoint. Professional organizations like AAPS play a crucial role in networking and fellowship, providing opportunities for collaboration and learning in the pharmaceutical industry. Sound Bites "I have just a passion for reptiles and have accumulated a small and pretty rare collection of reptiles from around the world." “It's probably a good 10 years from the glimmer in a biochemist's eyes to on the market.” “There's a logarithmic difference between great and good.” “Just use your imagination on a way to tackle a disease and then find a way.” “Cell and gene therapy opens the door to a whole different category of opportunities.” “AAPS is just kind of part of my DNA.” Chapters 00:21 - Surprises in Dr. Vick's Career 02:24 - The Cyclical Nature of Technology 03:30 - Exploring the Pharmaceutical Potential of Venom 05:35 - Improvements in Cancer and Other Diseases In The Past 30 Years 10:13 - Educating Future Toxicologists about Reptiles and Pharmaceuticals 15:45 - Andrew Vick's Role as an Adjunct Professor at Ohio State University 21:21 - New News!! - Restoring Hearing in Children with Gene Therapy 27:27 - The Impact of Professional Organizations on the Industry, AAPS New News Story:  The 'little protein factory' that could: Regeneron gene therapy restores hearing in 2 children https://www.fiercebiotech.com/biotech/little-protein-factory-could-regeneron-gene-therapy-restores-hearing-2-kids  How to reach us: Dr. Andy Vick https://www.linkedin.com/in/andy-vick-4467189/   Attralus: https://www.attralus.com/ Dr. Chad Briscoe https://www.linkedin.com/in/chadbriscoe/  Celerion - https://www.celerion.com/   Gregory Austin https://www.linkedin.com/in/gregoryaustin1/  ECI - https://eci-rx.com /  Image credits: Pharmacognosy - https://pharmacognosy-phytochemistry-natural-products.pharmaceuticalconferences.com/events-list/industrial-pharmacognosy #biotechnology #science #research #toxicology #reptiles  #academia #cellgenetherapy #AAPS

Our guest today is Mike Cobb, co-founder & CEO of ECI Development and President of Gran Pacifica. Named among the “100 Outstanding CEOs in Central America” by Mercados & Tendencias, Mike left a successful career in the computer industry to pursue opportunities in the emerging real estate markets of Central America. In 1996, he co-founded Exotic Caye International, initially providing loans to North Americans buying properties in Belize and Honduras. As demand grew, the mortgage company transitioned into an international bank under Belize jurisdiction, expanding its financial services. Recognizing the demand for North American-standard real estate for Baby Boomers, Mike led ECI Development into property development. This included a resort on Ambergris Caye, Belize, and a master-planned community in Nicaragua. In 2006, ECI expanded into Costa Rica with a significant land acquisition. Currently, they are developing 200 condominium units on Ambergris Caye. Mike Cobb is also a prominent speaker at international conferences on real estate financing and development. Interview Links: ECI Development Website: https://ecidevelopment.com/ Subscribe To Our Weekly Newsletter: The Wealth Dojo: https://subscribe.wealthdojo.ai/ Download all the Niches Trilogy Books: The 21 Best Cashflow Niches Digital: ⁠⁠https://www.cashflowninjaprograms.com/the-21-best-cashflow-niches-book⁠⁠ Audio: ⁠https://podcasters.spotify.com/pod/show/21-best-cashflow-niches⁠ The 21 Most Unique Cashflow Niches Digital: ⁠⁠https://www.cashflowninjaprograms.com/the-21-most-unique-cashflow-niches⁠⁠ Audio: ⁠https://podcasters.spotify.com/pod/show/21-most-unique-niches⁠ The 21 Best Cash Growth Niches Digital: ⁠https://www.cashflowninjaprograms.com/the-21-best-cash-growth-niches⁠⁠ Audio: ⁠https://podcasters.spotify.com/pod/show/21-cash-growth-niches Listen To Cashflow Ninja Podcasts: Cashflow Ninja ⁠https://podcasters.spotify.com/pod/show/cashflowninja⁠ Cashflow Investing Secrets ⁠https://podcasters.spotify.com/pod/show/cashflowinvestingsecrets⁠ Cashflow Ninja Banking ⁠https://podcasters.spotify.com/pod/show/cashflow-ninja-banking⁠ Connect With Us: Website: http://cashflowninja.com Podcast: http://resetinvestingsecrets.com Podcast: http://cashflowinvestingsecrets.com Podcast: http://cashflowninjabanking.com Substack: https://mclaubscher.substack.com/ Amazon Audible: https://a.co/d/1xfM1Vx Amazon Audible: https://a.co/d/aGzudX0 Facebook: https://www.facebook.com/cashflowninja/ Twitter: https://twitter.com/mclaubscher Instagram: https://www.instagram.com/thecashflowninja/ TikTok: https://www.tiktok.com/@cashflowninja Linkedin: https://www.linkedin.com/in/mclaubscher/ Gab: https://gab.com/cashflowninja Youtube: http://www.youtube.com/c/Cashflowninja Rumble: https://rumble.com/c/c-329875

This episode is sponsored by AlixPartners The Disruption Matters special podcast miniseries is back for a third season, and this year, leading industry experts will discuss how private markets can best use today's technologies to create value. In this second episode, we explore how technology is changing the nature of due diligence. How much can AI improve investment decisions? Is it only a matter of data management, or can these new technologies help identify potential operational efficiencies, EBITDA growth and new markets? And is this reserved for tech-forward industries like SaaS or can they be applied to sectors like manufacturing and insurance? We answer these questions with what's possible today, complete with the limitations and the need for expert supervision. Listeners should know that this episode ends with a plot twist that might keep GPs up at night. Guests include Anders Thulin, partner and head of digital & technology practice at Triton Partners; Andrew Tarver, founding partner of Motive Partners; Hoyoung Pak, a partner and managing director with AlixPartners; Jason McDannold, partner and managing director with AlixPartners; Lewis Bantin, partner at ECI; Sofia Gertsberg, managing director of quantitative investment science at HarbourVest; and Jeremy Lehman, director at Alix Partners. Clips: - Alien. Dan O'Bannon. 20th Century-Fox, Brandywine Productions. - Star Wars: The Force Awakens. JJ Abrams. Lucasfilm Ltd, Bad Robot, Walt Disney Studios Motion Pictures.

The recent spate of violence in Sub-Saharan Africa is centuries in the making, and finding solutions isn't easy. And when we talk about lifting the world out of poverty, Africa is at the center of any meaningful discussion.  Abraham Leno, Executive Director of the Eastern Congo Initiative, has worked on the African continent for decades, and he joins Ray Suarez to share how ECI is working to change narratives about people in Eastern Congo.  Guest: Abraham Leno, Executive Director of the Eastern Congo Initiative  Host:   Ray Suarez If you appreciate this episode and want to support the work we do, please consider making a donation to World Affairs. We cannot do this work without your help. Thank you.

ये अंक २०१९ लोक सभा चुनाव के पहले प्रकाशित किया गया थाइलोन मस्क के EVM से जुड़े ट्वीट ने इस मशीन को एक बार फिर अख़बारों के प्रथम पृष्ठ पर ले आया है | तो पुलियाबाज़ी में हमने इस प्रश्न से हटकर मतदान प्रक्रिया को समझने का प्रयास किया | इस पुलियाबाज़ी में हमारे गेस्ट है श्री अलोक शुक्ला जो २००९ और २०१४ के बीच भारत के डिप्टी इलेक्शन कमिश्नर रह चुके हैं | उनकी किताब Electronic Voting Machines: The True Story इवीएम पर लग रही आलोचनाओं का मुँहतोड़ जवाब देती है | इस पुलियाबाज़ी में हमने उनके सामने यह सवाल रखे:* संसद चुनाव के लिए प्रक्रिया कब और कैसे शुरू होती है ?* चुनाव आयोग एक स्वतन्त्र संवैधानिक संस्था है - इस संरचना का ECI अफसरों पर आपके मुताबिक क्या फ़र्क पड़ता है? क्या सब पार्टियाँ चुनाव आयोग के पास चुगली करने आती रहती है?* EVM के आने से पहले क्या तकलीफें होती थी चुनाव करवाने में ?* EVM का आईडिया कब पहले आया? क्या क्या विरोध रहे है EVM के ख़िलाफ़?* EVM और राजनैतिक दलों का रिश्ता कैसा रहा है?* EVM की छवि सुधारने के लिए ECI को क्या करना चाहिए?In the 1971 General Elections, it was alleged that ballot papers were tampered with vanishing and reappearing ink such that the vote stamp miraculously disappeared from another candidate and reappeared against the Congress candidate instead. This is not different from today when political parties blame the Electronic Voting Machine for their losses. Elon Musk's recent tweet is another instantiation of this debate.So, in this episode, we investigate the Indian electoral process and the EVM itself. To help us understand this better, we are joined by Dr Alok Shukla, who served as Deputy Election Commissioner between 2009 and 2014. Dr Shukla has served as an international observer for elections in several countries and has been decorated with the Prime Minister's Award for Excellence in Administration in 2010. His latest book, Electronic Voting Machines: The True Story, is an authoritative account of electronic voting machines.(This is a retelecast of an episode we recorded in 2019 before the Lok Sabha elections that year)सुनिए और बताइये कैसा लगा यह एपिसोड आपको।If you have any comments or questions, please write to us at puliyabaazi@gmail.com Follow us on Twitter: https://twitter.com/puliyabaazi Instagram: https://www.instagram.com/puliyabaazi/ This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.puliyabaazi.in

Episode Topic: Welcome to an insightful episode of PayPod. We engage Rich Itri, the Chief Innovation Officer at ECI, to explore the evolution and future of financial technology. The conversation delves deep into the world of AI regulation by ECI solutions, providing listeners with an understanding of how secure, compliant AI solutions are becoming integral in the financial sector. Rich shares his journey from his early days with an IBM PCjr to his current role, highlighting the pivotal moments and technological advancements that have shaped his career. Lessons You'll Learn: Listeners will gain valuable insights into the importance of AI regulation by ECI Solutions and its impact on the fintech industry. Rich Itri discusses the necessity of integrating secure and compliant AI solutions to protect sensitive financial data. You'll learn about the challenges and strategies involved in implementing AI technologies in a highly regulated environment, as well as the significance of maintaining data security. Rich also shares practical advice on aligning technology with business goals, understanding the regulatory landscape, and leveraging AI to enhance operational efficiency. T About Our Guest: Rich Itri is the Chief Innovation Officer at ECI Solutions, a leading provider of global technology solutions. With a career spanning over 27 years in the financial services industry, Rich brings a wealth of experience and expertise in technology and innovation. His journey began with an IBM PCjr, igniting a lifelong passion for technology that has driven his professional path. At ECI, Rich focuses on developing secure, compliant AI solutions and advising clients on leveraging technology to achieve business goals. His deep understanding of the fintech landscape and commitment to innovation make him a pivotal figure in the industry, offering invaluable insights into the future of financial technology. Topics Covered: The episode covers a range of topics, from the early days of personal computing to the latest advancements in AI and fintech. Key discussions include the evolution of financial technology, the role of data security, and the importance of AI regulation by ECI Solutions. Rich Itri shares his experiences with early computers like the IBM PCjr and Commodore 64, his transition from finance to technology, and his current work at ECI. The conversation also touches on the challenges of implementing AI in a regulated environment, the future of fintech, and practical advice for aligning technology with business objectives.

UKG announced during the 42nd annual Payroll Congress Convention and Expo that it is transforming payroll reporting with generative AI. Sage launched two new suites in Canada and the UK, Sage for Accountants & Sage for Small Business, to transform how SMBs and accounting practices operate and grow their business. ServiceNow and Microsoft announced an expanded strategic alliance, combining their generative AI capabilities to enhance employee choice and flexibility. ECI announced a new interface for ECinteractivePLUS, its native e-commerce platform for DDMSPLUS, which is ECI's complete Enterprise Resource Planning (ERP) software built specifically for business products dealers. IFS has appointed Kevin Price as Global Head of Enterprise Asset Management.Connect with us!https://www.erpadvisorsgroup.com866-499-8550LinkedIn:https://www.linkedin.com/company/erp-advisors-groupTwitter:https://twitter.com/erpadvisorsgrpFacebook:https://www.facebook.com/erpadvisorsInstagram:https://www.instagram.com/erpadvisorsgroupPinterest:https://www.pinterest.com/erpadvisorsgroupMedium:https://medium.com/@erpadvisorsgroup

This is the Catch Up on 3 Things for the Indian Express and I'm Flora Swain.It's the 24th of April and here are today's headlines.Prime Minister Narendra Modi accused the Congress of stabbing Babasaheb Ambedkar in the back by promising to give reservations based on religion. Speaking at a rally in Madhya Pradesh, he said our Constitution bars reservation on the basis of religion, but the Congress promised it in their poll manifesto. Meanwhile, Congress leader Rahul Gandhi said that PM Modi has “panicked after seeing after seeing our revolutionary manifesto”. He said the Congress manifesto aims to give back 90% Indians a part of Rs 16 lakh cr given to big businessmen as a loan waiver.The Supreme Court today reserved judgment on a batch of petitions seeking 100 per cent cross-verification of vote count in electronic voting machines (EVMS) with voter verifiable paper audit trail paper slips. Earlier in the day, the court posed a set of queries to the Election Commission of India (ECI) on the functioning of EVMs and sought the presence of an ECI official in the court to answer them.A day after the chairman of Indian Overseas Congress Sam Pitroda was on the receiving end over his comments on the US inheritance tax, he issued a clarification saying that his statements were twisted. He added that the comments had nothing to do with the Congress party or their manifesto for the upcoming Lok Sabha polls. The comments, however, faced the backlash of the BJP with their spokesperson Shehzad Poonawalla saying that the “Congress want to grab ones hard earned tax payed resources”.Day after the Supreme Court questioned the size of the public apology issued by Patanjali Ayurved over misleading advertisements, the firm issued another unconditional apology in newspapers on Wednesday — this time, more prominent. The apology mentioned non-compliance with the court's orders and directives and for errors in their advertisements. They expressed their commitment to avoiding such mistakes in the future and pledged to adhere to the court's instructions diligently and sincerely.Iran and Pakistan called on the United Nations Security Council in a joint statement issued today to take action against Israel. The statement released by Pakistan's foreign ministry, read, quote, "Recognizing that the irresponsible act of the Israeli regime forces was a major escalation in an already volatile region, both sides called on the UN Security Council to prevent the Israeli regime from its adventurism in the region and its illegal acts attacking its neighbours...," This a three-day visit to the country by Iranian President Ebrahim Raisi at a time of heightened tensions in the Middle East.This was the Catch-Up on the 3 Things by The Indian Express

New data on both immigration and inflation defied predictions and may have shifted the Fed's perspective. Our Chief U.S. Economist and Head of U.S. Rates Strategy share their updated outlooks. ----- Transcript -----Ellen Zentner: Welcome to Thoughts on the Market. I'm Ellen Zentner, Morgan Stanley's Chief US Economist.Guneet Dhingra: And I'm Guneet Dhingra, Head of US Rates Strategy.Ellen Zentner: And today on the podcast, we'll be discussing some significant changes to our US economic outlook and US rates outlook for the rest of this year.It's Tuesday, April 23rd at 10am in New York.Guneet Dhingra: So, Ellen, last week you put out an updated view on your outlook -- with some substantial forecast changes. Can you give us the headlines on GDP, inflation and the Fed forecast path? And what has really changed versus your last update?Ellen Zentner: Sure Guneet. So, our last economic outlook update was in November last year. And since that time, really, the impetus for all of these changes came from immigration. So, we got new immigration data from the CBO, and just to give you a sense of the magnitude of upward revision, we thought we had an increase of 800,000 in 2023. It turns out it was 3.3 million. And so far, the flows of immigrants suggest that we're going to get about as many as last year, if not a little bit more. And so, what does that mean? Faster population growth, those are more mouths to feed. You've got a faster labor force growth. They can work. They are working. And data historically shows that their labor force participation rates are higher than native born Americans.So, you've got to take all this into account. And it means that you've got this big positive supply side shock. And so, when the labor market has been about balance now between demand and supply, as Chair Powell's been noting, you're now going to have supply outrun demand this year.And so, you basically got much more labor market slack. You've got -- and I'm going to steal Chair Powell's words here -- you've got a bigger economy, but not a tighter economy. So, it's faster GDP growth. We have taken out one Fed cut, and I know we're going to talk about that because inflation has surprised the upside recently. But you've got slower wage growth. More labor market slack. And so, we did not change our overall inflation numbers on the back of this better growth and better labor force growth.Guneet Dhingra: That's very helpful. That's a very interesting read in the economy, Ellen. Do you think the Fed is reading the supply side story the same way as you are? And said differently, is the Fed on the same page as you? And if not, when do you think they could be?Ellen Zentner: Yeah. So, you know, Chair Powell, if you go back to his speeches and the minutes from the Fed. They've been talking about immigration. I think we've known for a while that the numbers were bigger than previously thought. But how you interpret that into an outlook can be different. And it takes some time. It even took us some time -- about a month -- to finally digest all the numbers and figure out exactly what it meant for our outlook. So, here's the biggest, I think, change for them in terms of what it means. The break-even level for payrolls is just that much higher.Now what does break even mean? It means it's the pace of job gains you need to generate each month in order to just keep the unemployment rate steady. And six months ago, we all thought it was 100, 000, including the Chair. And now we think it's 265,000. That is eye popping. And it means that when you see these big labor market numbers -- 250, 000; 300,000. That's normal. And that's not a labor market that's too tight.And so, I think the easiest thing the Fed, has realized is that they don't need to worry about the labor market. There's a lot more slack there. There's going to be a lot more slack there this year. Wage growth has come down because of it. ECI, or Employment Cost Index, is going to come down for this year. The unemployment rate is going to be higher. They do still need to reflect that in their forecast. And that means that we could show, sort of, this flavor of bigger but not tighter economy when we get their forecast updates in June.Guneet Dhingra: I think the medium-term thesis is very compelling, Ellen, but how do you fit the three back-to-back upside surprises in CPI here? How does that fit with the labor supply story?Ellen Zentner: So, that is sort of disconnected from the bigger but not tighter economy, because we did have to take into account that inflation has surprised to the upside. I mean, these have been some real volatile prints in the last three months, and we're now tracking March core PCE at 0.25 per cent and we're going to get that number later this week. And so that's above the threshold that we think the Fed needs in order to gain confidence that that pace of deceleration we saw late last year, is not in danger of slowing down for them to gain further confidence.Ellen Zentner: And so, the way I would characterizes this is that it's a bigger but not tighter economy. But we also had to take into account these inflation upside surprises, which is really what led us to push the June cut off to July.So, after we get that March, core PCE print, let's see what that data holds, but we think a few prints around 0.2 per cent are needed to satisfy Chair Powell, and gain that consensus to cut. So, I want to stress to the listeners that, you know, our conviction that inflation will head toward target remains high.And it was also helped last week by fresh data on new tenant rents. So that is a leading indicator for rental inflation in our models. And it's slowed again. And suggests an even faster pace of deceleration ahead.But here's where I think it matters for the Fed. Whereas before, they were very convicted that this rental inflation story was going to play out, that rent inflation was going to come down. They used similar models to us. But because of the inflation data being so volatile over the past three months, rather than providing forward guidance on what you're going to do around rental inflation coming down, you want to see it. You want to see it in the data. And so that's why they've been so willing to say, you know what, we're just going to, we're going to hold longer here.Guneet Dhingra: Perfect. So just to get the Fed call on the record, what exactly are you calling for the Fed? And I know investors love the hypothetical question. What is the probability in your mind that the Fed doesn't cut at all in 2024?Ellen Zentner: Yeah, they do love scenario analysis. So here we go. So, our baseline is they cut in July. They skip September. By November, the inflation data is coming down to monthly prints that tell them they're on track for their 2 per cent goal and at risk of falling below it. So, from November to June next year, they're cutting every meeting to roughly around three and a half percent.Now, as you asked, what if inflation doesn't go down? So, inflation doesn't go down, you know, then the Fed's forecast and our forecast are going to be wrong and the three rate cuts they envision is predicated on that inflation forecast coming true. So, you know, the most important takeaway from that scenario is that the result would be a Fed on holder for longer. But as opposed to a hike being the next move -- and I think that's really important here. The Fed is still very strongly convicted on they will cut this year. This is about the timing. Now, the hold period could last into 2025, I mean, we don't know, but what happens if inflation accelerates from here?So, I'm going to provide another scenario here. So, there is a scenario where inflation accelerates on a backdrop of strong growth, which would suggest it might be sustained, and perhaps begins to lift inflation expectations. Now, you know, that's a recipe for a hold that then turns into additional hikes as the Fed realizes neutral is just higher than where rates currently sit. But at this point, I would put quite a low probability on that scenario. But from a risk weighted perspective, I suppose it should be taken into account.So, given all this and the changes that we've made, what is your expectation for rates for the rest of the year?Guneet Dhingra: Yeah, I think we also, based on the forecast revision you guys have, we also revised up our treasury yield forecast. We earlier had 10 year yields ending slightly below 4 per cent by the end of 2024. Now we have them at about 4.15 percent which again is a 20-basis point uplift from our forecast before this. But still, I think it's not the higher for longer number that people are expecting because when I look at the forecast you have on the Fed, I think Fed path you have is well below what the markets expect.I think the forecast you have has about seven cuts from July this year to the middle of next year. The market for contrast is only four. There's a pretty massive gap that opens up, I think, between the way we see it -- and ultimately that does come down to the interpretation of the data that we're seeing so far.So, for us, the forecast numbers are slightly higher than before, but the message still is: we are not in the hire for longer camp, and we do expect rates to end up below the market applied forwards.Ellen Zentner: All right. So, you know, I've talked a lot about immigration. One could say I've been pretty obsessed with it over the last couple of months. But from a rates perspective, you know, what are the broader implications of the immigration story for that? You know, this, this bigger but not tighter economy. How do you translate that into rates?Guneet Dhingra: Yeah, let me say your obsession has been contagious. You know, I've caught on to that bug, the immigration bug. And, you know, I've been I've been discussing this thesis with investors, quite a lot. And I think it seems to me as you framed it pretty nicely. It's a bigger but not a tighter economy. I don't think investors have caught on to that page yet. I think most investors continue to think of these inflation prints is telling you that this is a tighter economy. Bigger, yes -- maybe on the margin. But the tighter part is still very much in people's minds. And when I look at the optics off the CPI numbers, the payroll numbers, investors have just been very conditioned, very reflexively conditioned to look at a 250K number on payrolls as a very strong number. They look at the 3 per cent number of GDP as a very strong number.And as you laid out earlier, these numbers may not be necessarily telling you about an overheating economy. But simply a bigger economy. So, I think the disconnect is there, pretty pervasive. And I think for me, most investors will take a lot of time to get over the optics. The optics of three strong points of inflation, the optics of 250K payrolls. I think it's gradually seeping in. But for now, I think the true impact or the true learnings from the immigration story is not very well understood in the investment community.Ellen Zentner: Okay, but is there, is there anything else missing in your view?Guneet Dhingra: Yeah, quite a few things. I think you can add more nuances to this immigration story itself. For example, when I think about last year, when rates were going up massively in third quarter, fourth quarter, one of the focal points was Atlanta Fed GDP Now. My GDP now was tracking close to four and a half, five per cent, and inflation was cooling pretty clearly in the second half of last year. And so investors had a choice to make. Do we actually trust the GDP growth numbers? Because they are probably an inflation risk in the future. And the markets very clearly chose to focus on growth with the belief that this growth is eventually going to lead to high inflation. And so, I think that disconnect has really translated into, sort of, what I would call like a house of cards where investors have built the entire market level on growth upside, and growth upside, and growth upside.So, I think the market level -- when I do the math and try and suss out the counterfactual -- the market level of 4.6 per cent tenure should have and could have been a market level of 3.8 per cent tenure based on my calculations. And so, there's an 80-basis point gap from where we are to where we could have been based on a misunderstanding of the supply story and the immigration story.Ellen Zentner: Yeah, I certainly wish the volatility was a lot lower here. It would make it easier for the Fed and for us to separate signal from noise. Certainly difficult for market participants to do that. But Guneet, thanks for taking the time to talk.Guneet Dhingra: Great speaking with you, Ellen.Ellen Zentner: And thanks for listening. If you enjoy Thoughts on the Market, please leave us a review wherever you listen to podcasts and share the podcast with a friend or colleague today.

Supreme Court's stern stance on EVMs: Prashant Bhushan's critique, court's support for ECI, and the ongoing debate over paper ballot. Get the latest insights on electoral technology and the legal landscape.

Deltek unveiled Dela, its AI-powered, intelligent business companion. QAD released the latest enhancements to its comprehensive suite of Adaptive Applications. ECI announced that its job shop product, JobBOSS2, has now integrated uniPoint to deliver advanced quality management and enhanced customer service. Microsoft announced new Microsoft Dynamics 365 and Microsoft Copilot innovations for supply chain, sales, and service in the 2024 release wave 1. OneStream Software announced its Annual Recurring Revenue (ARR) is over $450 million, up 34% year-over-year, as of the first quarter ended March 31, 2024.Connect with us!https://www.erpadvisorsgroup.com866-499-8550LinkedIn:https://www.linkedin.com/company/erp-advisors-groupTwitter:https://twitter.com/erpadvisorsgrpFacebook:https://www.facebook.com/erpadvisorsInstagram:https://www.instagram.com/erpadvisorsgroupPinterest:https://www.pinterest.com/erpadvisorsgroupMedium:https://medium.com/@erpadvisorsgroup

Welcome back to the Alt Goes Mainstream podcast.Today we have the operator's view on the show. We bring in someone who rose up the ranks of a private equity-backed software company to be CEO of that company — ECi Software Solutions — that now generates over $500M in revenue and $200M in EBITDA.We welcome Ron Books, now an Operating Partner at Carlyle and the CEO at Net Health, a Carlyle portfolio company. He also sits on a number of boards for Carlyle.He is now the Chairman and is the former CEO of ECi Software Solutions, a leading global provider of cloud-based software for SMEs, which he successful sold to Leonard Green & Partners for a multi-billion dollar exit. Ron started with ECi when it was a startup company and rose in the organization to serve as VP Sales, then COO, and then CEO, a position which he held from 2009 to 2021. While serving as CEO, Ron and his team developed and executed a strategic plan that included overseeing 46 M&A transactions and a successful software license to cloud migration across nearly a dozen platforms. They received investment from — and sold the business to — Insight Partners, Carlyle, Apax Partners, Goldman Sachs, and most recently, Leonard Green & Partners. Under his leadership as CEO, ECi grew from less than $50M in revenue to over $500M and a sale of the company in 2020 at a multi-billion dollar valuation.Ron has all the hallmarks of a successful entrepreneur — energetic yet thoughtful, a tireless work ethic, the ability to connect with customers and employees, and loyalty to both customers and employees.Ron and I had a fascinating conversation about what it takes to build a great company and culture and how to work with private equity given that he's been on both sides of the table. We discussed:Lessons learned from growing a business to $500M in revenue and $200M in EBITDA.How he built and grew ECi through acquisitions and globalizing the business.Why culture matters and how to vet for culture in the hiring process.Stories from the challenges and successes of integrating 41 companies via M&A.How founders should think about working with private equity firms.How founders can get the most out of their board members and operating partners.The transition from CEO to Operating Executive back to CEO.Thanks Ron for coming on the show to share your wisdom and experiences that are an invaluable source of learnings for both founders and investors.

Workday announced the availability of Workday Adaptive Planning and Consolidation, a new solution that brings together the agile planning of Workday Adaptive Planning and the comprehensive close and consolidation capabilities of Workday Financial Management. ECI announced a new strategic alliance with Pros Elite Group, an operations, sales, and analytics provider. Unit4 announced the launch of Smart Automation Services to enable its customers to leverage AI and context awareness capabilities to improve efficiency and productivity. Acumatica announced the general availability of Acumatica 2024 R1, the first of its semiannual product releases, as previewed at the Acumatica Summit 2024.Connect with us!https://www.erpadvisorsgroup.com866-499-8550LinkedIn:https://www.linkedin.com/company/erp-advisors-groupTwitter:https://twitter.com/erpadvisorsgrpFacebook:https://www.facebook.com/erpadvisorsInstagram:https://www.instagram.com/erpadvisorsgroupPinterest:https://www.pinterest.com/erpadvisorsgroupMedium:https://medium.com/@erpadvisorsgroup

This is the Catch Up on 3 Things for the Indian Express and I'm Flora Swain.It's the 20th of March and here are today's headlines.Prime Minister Narendra Modi today said that India has emerged as the world's third largest startup ecosystem with over 1.25 lakh startups and 110 unicorns, and is charting a roadmap for becoming a developed nation with right decisions taken at the right time. Speaking at the Startup Mahakumbh event, Modi said India's startup ecosystem is not limited to metro cities, it has now become a social culture. The PM vowed that he will make India the world's third largest economy in his third term, and asserted that startups will play a big role in India's progress.Days after the Election Commission of India directed the transfer of the home secretaries in six states, including Uttarakhand, the Uttarakhand Congress has requested that Director General of Police Abhinav Kumar also be removed from his post, saying that his “closeness to the ruling party is well known”. In a letter to the ECI, the Uttarakhand Congress president Karan Mahara said that the “loyalty of the present DGP of the state to the ruling party” raises questions on the fairness of the elections.From claiming that he has received an “overwhelmingly positive” response to Zomato's plans of launching a separate delivery fleet for vegetarian food, the company's co-founder and CEO Deepinder Goyal has changed track in less than 11 hours. The food delivery service provider has now decided against the segregation of the fleet on the ground basis of people's dietary choices. Concerns that the segregation of workers into green and red clothes could result in potential harassment on the ground, has now resulted in Zomato rolling back the green uniforms.The World Happiness Report for 2024 was released earlier this week, noting that while the top 10 countries in the list have remained the same since before the Covid-19 pandemic.  Finland topped the list for the seventh year in a row, followed by Denmark, Iceland and Sweden. India ranked 126th in the list. The report observed that in India, older age is associated with higher life satisfaction. However, older Indian women reported lower life satisfaction than older men.New Zealand said on Wednesday it will ban disposable e-cigarettes, or vapes, and raise financial penalties for those who sell such products to minors. The move comes less than a month after the government repealed a unique law enacted by the previous left-leaning government to phase out tobacco smoking by imposing a lifetime ban on young people buying cigarettes.This was the Catch-Up on the 3 Things by The Indian Express.

This is the Catch Up on 3 Things for the Indian Express and I'm Flora Swain.It's the 18th of March and here are today's headlines.The Supreme Court's Constitution bench hearing the electoral bonds matter today asked the State Bank of India to also disclose the unique alphanumeric code on the bonds to the Election Commission of India. The bench also asked the Chairman and Managing Director of SBI to file an affidavit on or before 5 pm on 21st of March stating that the bank has disclosed all details of the bonds to the ECI.The Election Commission of India today transferred the Home Secretaries of six states — Gujarat, Uttar Pradesh, Bihar, Jharkhand, Himachal Pradesh and Uttarakhand to ensure level-playing field for the upcoming elections to the Lok Sabha. The poll regulating body also removed West Bengal Director General of Police, Rajeev Kumar.The poll panel under CEC Rajiv Kumar also removed secretary of the general administrative departments of Mizoram and Himachal Pradesh and ordered removal of Brihanmumbai Municipal Commissioner Iqbal Singh Chahal, additional commissioners and deputy commissioners.Tamilisai Soundararajan today resigned as the Governor of Telangana and the Lieutenant Governor of Puducherry. While the sudden decision has come as a surprise, Soundararajan, is expected to return to electoral politics and contest Lok Sabha elections 2024 from Tamil Nadu. A press release from the Telangana Raj Bhavan stated that the resignation has been submitted to the Hon'ble President of India. In September 2019, Soundararajan, the then-state president of the Tamil Nadu unit of the BJP for five years, took to the office of Telangana Governor and later took additional charge as the Lieutenant Governor of Puducherry in February 2021.Alleging that the INDIA bloc's manifesto talks about finishing ‘Shakti', Prime Minister Narendra Modi today said the fight is between those who want to destroy ‘Shakti' and those who worship them. Addressing a rally in Telangana's Jagtial, Modi said, for him, every mother and every daughter is a form of ‘Shakti' and that he worships them. He said the nation dedicated ‘Chandrayaan's' success to ‘Shiv Shakti' and the opposition parties are talking of destroying ‘Shakti'.President Vladimir Putin won a record post-Soviet landslide in Russia's election on Sunday, cementing his grip on power though thousands of opponents staged a noon protest at polling stations. He will easily secure a new six-year term that would enable him to overtake Josef Stalin and become Russia's longest-serving leader for more than 200 years. However, the results have been met with criticism from Western countries like the United States, the United Kingdom, and Germany, among others, who accused Putin of winning through an unfair electoral process held amidst the imprisonment of opposition leaders.This was the Catch-Up on the 3 Things by The Indian Express.

Owning raw land, timberland, and farmland is often the domain of the wealthy. This is partly because it is difficult to obtain loans for this property. Today, we discuss an income-producing timberland that also tends to increase in value. For under $7,000 you can own quarter-acre parcels of producing teak trees in Panama and Nicaragua. You can invest yourself. All at once, this provides diversification with a hard asset in a foreign nation and a different product type. Over a twenty-five year period, each $7K quarter-acre teak parcel is projected to return $94K. You get title to the property. Learn more at: www.GREmarketplace.com/Teak With ownership of two quarter-acre parcels, you can qualify for a second residency in Panama for under $22K with legal fees, etc. A SFR does not grow into a duplex. But teak trees grow in volume while its unit price typically appreciates. Teak price growth is historically 5.5% annually. I've met the company CEO and Chairman in-person. This provider has offered this opportunity for 24+ years. They've recently added a sawmill, increasing profits. What are the risks of teak tree investing? Disease, pests, fire, geopolitics and more. They are proven mitigation plans. In-person teak tours for prospective investors are offered. Trees grow through recessions, COVID, market cycles, and Fed rate decisions. Learn more about teak tree investing at: GREmarketplace.com/Teak Timestamps: Welcome to Get Rich Education (00:00:01) Keith Weinhold introduces the podcast and emphasizes the importance of real estate and financial information. The US economy and land ownership (00:01:44) Keith discusses the strength of the US economy and the importance of diverse and resilient real estate portfolios. America's top 100 landowners (00:02:29) Keith talks about the largest landowners in America and the reasons why land ownership is often associated with the wealthy. Investing like a billionaire (00:05:32) Keith introduces the topic of investing in producing land and the benefits of owning producing land. Introduction to ECI Development (00:06:21) Keith introduces Michael Cobb and discusses the company's projects in Latin America. Marriott resort project in Belize (00:07:08) Mike talks about the construction of a Marriott resort in Ambergris Key, Belize, and the challenges of financing such projects. Development and tourism in Belize (00:08:37) Michael Cobb discusses the development and popularity of Ambergris Key, Belize, and the involvement of major hotel brands. Teak tree parcels investment (00:11:30) Michael Cobb explains the investment opportunity in quarter-acre teak tree parcels and the generational wealth stewardship associated with it. Reasons for teak investing (00:14:05) Michael Cobb discusses the reasons why people are interested in teak investing, including hard asset diversification and international residency opportunities. Cash flow cycles and teak investment (00:16:42) Michael Cobb explains the 25-year cash flow cycle associated with teak investments and the generational income potential. Optimal growing conditions for teak (00:19:26) Michael Cobb discusses the optimal growing conditions for teak and the physical growth of the trees. [End of segment] Teak Plantation Locations and Growth (00:19:42) Discussion on the optimal locations for teak growth and the historical track record of teak price growth. Teak Price Growth and Business Plan (00:20:44) The historical 55% annual increase in the value of teak and the business plan's conservative approach to teak price growth. Physical Properties and Residency Opportunities (00:21:33) The value of teak and the opportunities for achieving residency in Panama by owning teak. Residency and Citizenship (00:24:33) Differentiating between residency and citizenship in Panama and the process and benefits of obtaining permanent residency. Sawmill and Value-Added Component (00:27:56) The integration of a sawmill into the investment proposition and the value-added potential of processing teak into lumber. Sawmill Investment Opportunity (00:30:07) Details of the investment opportunity in the sawmill, including the expected return and investment structure. Risks and Mitigation (00:32:41) Discussion on the risks associated with teak plantation investment abroad and the mitigation strategies in place. Property Management and Tours (00:35:25) Outsourcing property management and the availability of tours to visit the teak plantations in Panama. Long-Term Investment Perspective (00:37:43) The long-term growth potential of teak investments and the comparison to the investment strategies of wealthy families and institutions. Earth's Highest Real Estate (00:38:11) Discussion about Earth's highest point, the equatorial bulge, and the location of teak plantations in Panama and Nicaragua. Investing in Teak Parcels (00:38:11) Information about purchasing teak parcels, the absence of loans, and the potential for building wealth through teak investments. Consultation Disclaimer (00:39:34) Disclaimer about seeking professional advice and the potential for profit or loss in investment strategies. Resources mentioned: Show Page: GetRichEducation.com/490 Learn more about teak investing: GREmarketplace.com/Teak For access to properties or free help with a GRE Investment Coach, start here: GREmarketplace.com Get mortgage loans for investment property: RidgeLendingGroup.com or call 855-74-RIDGE  or e-mail: info@RidgeLendingGroup.com Invest with Freedom Family Investments.  You get paid first: Text FAMILY to 66866 Will you please leave a review for the show? I'd be grateful. Search “how to leave an Apple Podcasts review”  Top Properties & Providers: GREmarketplace.com GRE Free Investment Coaching: GREmarketplace.com/Coach Best Financial Education: GetRichEducation.com Get our wealth-building newsletter free— text ‘GRE' to 66866 Our YouTube Channel: www.youtube.com/c/GetRichEducation Follow us on Instagram: @getricheducation Keith's personal Instagram: @keithweinhold   Complete episode transcript:   Keith Weinhold (00:00:01) - Welcome to gray. I'm your host, Keith Reinhold. An affordable way to simultaneously invest like a billionaire. Get diversified in multiple ways with real estate. Help the earth. And if you prefer, even achieve residency in a second nation today and get rich education. When you want the best real estate and finance info, the modern internet experience limits your free articles access, and it's replete with paywalls. And you've got pop ups and push notifications and cookies. Disclaimers are. At no other time in history has it been more vital to place nice, clean, free content into your hands that actually adds no hype value to your life? See, this is the golden age of quality newsletters, and I write every word of ours myself. It's got a dash of humor and it's to the point to get the letter. It couldn't be more simple text gray to 66866. And when you start the free newsletter, you'll also get my one hour fast real estate course completely free. It's called the Don't Quit Your Daydream letter and it wires your mind for wealth.   Keith Weinhold (00:01:16) - Make sure you read it. Text gray to 66866. Text gray 266866.   Corey Coates (00:01:28) - You're listening to the show that has created more financial freedom than nearly any show in the world. This is get rich education.   Keith Weinhold (00:01:44) - What category? From Sorrento, Italy to Sacramento, California, and across 188 nations worldwide. I'm Keith Reinhold, and you're listening to get Rich education the Voice of Real Estate since 2014. As we're two months into the year now and the US economy has continued to stay strong. Let me ask, how's your portfolio doing and how resilient is your real estate? How diverse is it? How would you grade yourself on those criteria?   Donald Trump (00:02:17) - I would give myself, I would look, I hate to do it, but I will do it. I would give myself an A-plus. Is that enough? Can I go higher than that?   Keith Weinhold (00:02:29) - Well, well, whether your, I guess, straight A's or not. Consider this land report.com. They recently published a report about America's top 100 Las donors. Now, Lynn could be vacant and nonresidential, yet have active ranching or agriculture or forestry taking place.   Keith Weinhold (00:02:52) - That way the land produces something while it might increase in value at the same time. But the reason that often land is the domain of the wealthy is that it's harder to get loans for land, and therefore one must often pay all cash. Well, by the time they were done. Today, you'll learn about producing land that's actually available at such a low price point that alone typically is not required for you to buy it. In 2024, America's largest land owner is Red Emerson, and that's what the report found. Read and his family owned 2.4 million acres in California, Oregon and Washington through their Timber products company and the number since they became America's largest landowners in 2021, when they acquired 175,000 acres in Oregon from another timber company. Well, with that acquisition, the Emerson surpassed Liberty Media chairman John Malone's 2.2 million acres. And then in third place is CNN founder Ted Turner. Yeah, he's America's third largest landowner, with 2 million acres in the southeast on the Great Plains and across the West. And it was a few years ago now.   Keith Weinhold (00:04:05) - It was 2020 when news broke that Microsoft co-founder Bill gates was America's largest farm land owner, with more than 260,000 acres. So the wealthy are attracted to real assets that can produce yield in something like land, which they aren't making more of. That's the backdrop for today. Surely we'll talk about income producing land, although most years it won't pay out and it's available to any investor, big or small. But before we do, let me share that. About ten days ago, I climbed up the highest point on Earth here while we're talking about non-residential real estate. Well, where was it? Where was I? Yes, I was on Earth's highest piece of real estate. Kind of a trivia question here, and I used to think that that must mean Mount Everest, but it's not. So there's a clue for you there. Where is Earth's highest point is you ponder that. I'll give you the answer later. Let's talk about investing like a billionaire with the opportunity to own producing land did it to you? We've discussed this topic before, but it's been quite some time and there have been some important updates, including a sawmill for the production timber.   Keith Weinhold (00:05:32) - After success in the computer industry, today's guest formed ECI development in 1996. I suppose going on nearly 30 years now. He served on advisory boards for the Na as a resort community developer. They have projects in Belize, Nicaragua, Costa Rica, El Salvador, Honduras and Panama, and neighborhoods include homes, condominiums, golf courses and over five miles of beachfront. So they got some really beautiful properties. He and I first met in person in 2016. He and his family lived in Central America from 2002 to 2016. It's always fantastic to have back on grea, and I guess I must button up here because it is the chairman and CEO, Michael Cobb. It's good to be with you. Thanks for having me.   Michael Cobb (00:06:21) - Back on the show. It's fun to have these conversations. I didn't realize we met in 2016. That's a little while ago.   Keith Weinhold (00:06:27) - Yeah, it has been eight years. Yes, we met in the region then down there and Mike's about the most relatable and down to earth guy that you can find and literally down to earth is.   Keith Weinhold (00:06:41) - Besides the resort development, you've made it easy and inexpensive for investors worldwide to buy producing teak tree parcels. But before we discuss that, you've got a project that's drawn a lot of interest on Ambergris Key, Belize, which many of our listeners already know, that's Belize's largest island and its top tourist destination. I have visited and owned property there, and it's coming online next year. It's pretty exciting. Tell us about it.   Michael Cobb (00:07:08) - It is exciting. It's been in the works for goodness, eight years. I think we signed our contract with Marriott maybe 7 or 8 years ago. We started construction just about a year ago last January. So almost exactly a year. Yeah, it's a marriott resort, 202 room oceanfront resort. It's fantastic. It will be done in August of 2025. Soft opening heart opening October 25th. So yeah, about 1618 months from now have this project finally finished. You know, the big challenging thing in this part of the world is financing. But it's really hard to get financing or affordable financing.   Michael Cobb (00:07:42) - Let me say it that way. Yeah. And so we took our time and we would not start a project until it was fully funded. I think a lot of challenges are people start these projects are kind of betting on the. Com. Right. Oh well we'll figure it out later. And we don't operate that way. We've been around for yeah 28 years. And so we're very very conservative. And until we had all the money to build the hotel, the resort, we did not start. And so we kicked it off last January. It was just down there last week. Steel is arriving. The superstructure is already going up. Yeah, man. It's just so nice to see it really coming to fruition. But you know, it's prudence and patience to take our time, make sure we have all the funding and then launch so that what we start finishes. And that's really been our mantra for almost three decades now.   Keith Weinhold (00:08:27) - Make it up, make it real, make it happen. In the largest town there on Ambergris Key, Belize, just a few decades ago, it was still this sleepy fishing village.   Keith Weinhold (00:08:37) - And with the setting that that island has and all the great snorkeling and everything else, it's really become popular and is boutique hotels grew into larger hotels. Yeah, it was probably, what, ten years ago perhaps, that you saw some of these big brands start to take more of an interest, like Hilton and Marriott, in branding the buildings what is.   Michael Cobb (00:09:00) - And, you know, I give a presentation called Why Belize, Why Right Now? And you nailed it there when you talked about the timelines. Right. And how a country or a region, it's not even a country in this case. Ambergris key. It's very specific. Right. How ambergris Key Belize has moved through this timeline, this path of progress. And at some point it goes from being a niche market or a no name market to a niche market, to a boutique market. And then all of a sudden, you're right, at some point the brand start to pay attention and then you move into popular acceptance and really mainstream tourism. And so, right.   Michael Cobb (00:09:31) - The cruise ships started going to Belize about 15 years ago, which put Belize as a country into the mind of a more mainstream traveler. And then you're right, about eight, ten years ago, the brand started to pay attention. And we do. We have a Hilton, we have a curio by Hilton, we have an autograph by Marriott, our company, ECI. We picked up the best Western franchise, and so we operate a Best Western on the island for that middle class market. And then Marriott, obviously, for the very high end traveler who wants an oceanfront 4 or 5 star kind of property. So yeah, but the brands are paying attention. And by the way, we're just seeing the beginning of that happening. This popularity curve Belize has entered what I would call the fast growth period. And over the next five, maybe eight years, we're going to see incredible growth in the tourism industry. Airlift is up. JetBlue just started flying down. So we're starting to WestJet. So we've got Canadian Air.   Michael Cobb (00:10:22) - We've got a discount carrier southwest. So when those things start to happen what you see is a market dynamism that's you know really it's exciting and it's going to change. Very, very rapidly. The pace of change is going to grow rapidly as well. So great time to look at Belize. If folks are interested in sort of that positioning in the path of progress in the marketplace.   Keith Weinhold (00:10:43) - Each time I visit Ambergris Key, Belize, the level of development increase is palpable. And, you know, this is an opportunity for a US or Canadian buyer or a buyer from outside that nation to come in. And it's just a very easy step with the English language and the common law in Belize, where you can invest yourself in this Marriott project that Mike discussed. Now, Mike, a while ago, to change topics, you recognize that the world has been really deforested and losing its valuable teak hardwood forests so continuously since 1999, you've offered a program so that individual investors at a really affordable price. We'll get to that price later.   Keith Weinhold (00:11:30) - They can own quarter acre parcels with the property deeded in their name, and reap the benefits and returns from the growth of the teakwood on top of the land. And now this is pretty novel, because for hundreds of years, only the hedge funds and super wealthy had access to an investment like this. So get us up to date with what you're doing on the teak hardwoods, because I know that so many of our listeners and viewers have already gotten involved.   Michael Cobb (00:11:56) - They haven't really. Thank you for being one of the people who put the word out there. Right? Because most people don't even know you can own teak or let's just back it up and you say, own timber, right? You start there. You're right. Only the super rich land barons, hedge funds. Those are the people that have always owned timber for centuries. Right. And so I think in most people's minds it's like, oh, I can't even get there. How would I even do that? Right. Well, then you take it overseas and you take it into something very, very specific, like teak timber.   Michael Cobb (00:12:25) - That's just not on anyone's radar. So. So you have done a great job. Thank you for getting the word out to just let folks know that this is something that they can do. So quarter acre teak parcels. We are now on our third plantation in Panama. We have one in Nicaragua as well. And so we're in our third plantation in Panama. Just because of the incredible number of folks, well over a thousand folks now who have decided they want to invest in own teak. You said something really interesting, Keith. You said you get to own the land, you get title to land and you get the harvest of the trees. That's absolutely correct. But it gets better because when the trees are harvested, they get replanted. And then the next generation of people your children, your grandchildren, whoever that might be, get the next harvest. But because you still own the land and the trees are replanted, a third harvest, you know, and a fourth harvest. So what you've really created with teak ownership is generational wealth stewardship.   Michael Cobb (00:13:24) - And that is something that's just so far beyond the comprehension of so many people that it can be so easy and so affordable to do.   Keith Weinhold (00:13:32) - I'm an investor myself in producing land like this in Latin America, so I know what some of my reasons are for being interested in this. And yes, it's more than the fact that I'm just a geography guy. It's the fact that I know I'm diversifying in multiple ways at the same time, a different product type in residential real estate. And I'm getting international diversification in a different nation, for starters. So are those some of the reasons that you see for why so many people are interested in teak investing like this? What are their reasons?   Michael Cobb (00:14:05) - Yeah, I think you've nailed a big part of it, which is the hard asset. A lot of folks, your listeners, readers in the news that are right, I mean, hard assets are important. I hope more people recognize that. Right. And more and more people are, thank goodness. So hard. Asset real estate being this particular hard asset.   Michael Cobb (00:14:22) - Right. And then the international diversification, one of the challenges we have is us, especially in Canadians to some degree, is that we kind of locked into the US system like we can own, say, Toyota stock, right? Japanese company, we can own Nestlé, a Swiss company, but generally we're doing it on the New York Stock Exchange. And so even if we own an international stock, it's still the US basket are still the Canadian basket that we hold it in. Right. And so when you physically own a titled property outside your home country, you have now truly diversified internationally. And there's a lot of prudence in that. And even just tiny little percentages of your portfolio, 5% of your portfolio, 10% of your portfolio outside your home country and hard assets is prudent because you want some other baskets for those nest eggs. Antiqued because it's such a low price point of entry with a huge yield, by the way, that it has become very, very popular for folks who want that international diversification in a hard asset.   Michael Cobb (00:15:23) - But to have the true international diversification because it's a physical asset outside your home country. And then I. Just say this and we can pick up on the theme or not. The other reason that people are looking at teak in Panama and Nicaragua, by the way, both countries, is because of the availability or the qualification for a visa for a second residency. And a lot of times people look at that as a plan B, if we kind of think maybe the US is going off the rails or Canada or wherever your home country is at, or it could go off the rails. Doesn't have to be now. It could be going off the rails in the future. You sort of that Boy Scout mentality of, you know what, I want a plan B, and if we have a second residency outside our home country, we now have an option. If we don't like the way things are going or where they get to, we can actually pick up and we can move and we have the right legal right, because we have a residency to live in another country.   Michael Cobb (00:16:17) - That's another reason that a lot of people have picked up the teak because it qualifies you for that residency. But I think the bigger reason is the international hard asset diversification. I think that's the leading reason people do it.   Keith Weinhold (00:16:31) - I want to ask you more about the residency shortly, but tell us more about the investment. We're thinking about maybe capital growth as the trees grow. And then what about the income?   Michael Cobb (00:16:42) - Sure. And so I think let me back it up. A lot of people think in cash flow cycles, right? If we have a job, we get paid every two weeks. You know, you have a lot of folks that have invested in properties. We get a monthly rent check, right? Or if we have stocks, maybe we get a quarterly or annual dividend. Right. So those are the what I would call the common time frames that we think about in cash flow. But what the Uber wealthy, what the hedge funds, what the family offices, what the endowment for places like Harvard, Yale, these big institution or big institutional thinkers have known for centuries is that there are actually other cash flow cycles that are largely ignored by the what I would say, the average investor.   Michael Cobb (00:17:21) - And those cash flow cycles are much longer. Teak, for example, is a 25 year cash flow cycle, right? You plant the trees and in 25 years you harvest them. You plant them again, not them. You plant new ones, right? In 25 years you harvest those and then so on and so on. So what you're creating is this 25 year cash flow machine. Now the kinds of returns are truly outsized. I mean you're talking about double digit ers. Now a lot of people say, well Mike, that's great. But what happens if I need the money in year 15? You can't have it because there is no money in year 15. Your trees are still growing, right? So it's this weird investment timeline. It's almost flatlined until the very end. And then it jumps way up and then it drops back down to a flatline again. And so it'd be silly to put tons of money into teak unless you had thousand times tons of money, right? But for some small piece of your investment portfolio where you have enough cash flow coming in from your maybe your job, your rent, your dividends, whatever, that a small piece that moves into this 25 year cash flow cycle with the thought process that this is how I steward wealth into the future, to children, grandchildren, great grandchildren, because the 25 year cycle is almost generational, right? In fact, in the US, it probably is generational because we're having children in the ages of, you know, 25 to 30.   Michael Cobb (00:18:44) - So it kind of starts to line up with generational income as opposed to, you know, sort of that whatever biweekly, monthly, yearly income. So it's just a different cash flow cycle.   Keith Weinhold (00:18:56) - That's right. And I brought up before that, when you think about the growth of one of your investments, you now get to think about it in two ways. If you own a duplex, it might have growth in its price. However, it doesn't grow into a fourplex and have growth in its price. However, with teak, you might have an increase in the value of the wood, perhaps on a board foot unit basis, and at the same time it is growing in height and volume.   Michael Cobb (00:19:26) - Absolutely no. That's a cute way to say it. I never really thought about a duplex growing into a fourplex, right? That's good. Exactly. And so what you do, you're right. You have the physical growth of the trees. And we have located our plantations in the optimal growing conditions, fatigue. And they are very known.   Michael Cobb (00:19:42) - Right? I mean, the British started plantation growing teak 350 almost 400 years ago in Southeast Asia. And so the Brits have just meticulously kept statistical records of every plantation that they were involved with the altitude, soil type, rainfall, temperature, on and on and on. And so it's really well known exactly where teak will grow well, and both where we have our plantations, it does Nicaragua and Panama, and we'll stick on Panama today, but the locations are dead center bull's eye locations for the best optimal growing of teak. So you have this growth of a physical thing, right. But you mentioned the board foot price. And by the way, the track record on teak being grown in plantations is 350 years. So what a track record, right? But since 1970. Two. The average price of teak over 5152 years has been 5.5% a year. That's the growth in the price of teak, right? And so you know who knows the future, right? I mean, the future is the future, right.   Michael Cobb (00:20:44) - But if a 50 year track record on a 5.5% increase in the value of the teak itself is pretty powerful, right? That's the long track record of nice growth. And when we factor in our teak into our business plan, we take that 5.5 and we make it zero. We just say, what if there is no increase in the price of teak over 25 years? How much will the tree grow? And if that tree is cut down and is sold as lumber? When we'll talk about our Solomon in a minute. If that tree is sold as lumber, what's the value of that lumber today? And what will the tree be worth in that value 25 years from now? And so if things do continue to increase at 5.5% a year, that's just all gravy. And that just starts to take that rate of return and just ratcheted up even further.   Keith Weinhold (00:21:33) - Teak has a number of physical properties that make it valuable, from its beauty to its fire resistance and more. Mike has now touched on a few interesting things.   Keith Weinhold (00:21:44) - We'll come back and talk about that soon, including how you can achieve residency in Panama by owning teak, what the risks are, and more about their sawmill that he just mentioned, adding value to the operation there. And then we're going to talk about what the prices are. We're talking with ECI Development Chairman and CEO Michael Cobb more when we come back. I'm your host, Keith Wynn. You know, I'll just tell you, for the most passive part of my real estate investing, personally, I put my own dollars with Freedom Family Investments because their funds pay me a stream of regular cash flow in returns, or better than a bank savings account, up to 12%. Their minimums are as low as 25 K. You don't even need to be accredited for some of them. It's all backed by real estate and that kind of love. How the tax benefit of doing this can offset capital gains and your W-2 jobs income. And they've always given me exactly their stated return paid on time. So it's steady income, no surprises while I'm sleeping or just doing the things I love.   Keith Weinhold (00:22:52) - For a little insider tip, I've invested in their power fund to get going on that text family to 66866. Oh, and this isn't a solicitation. If you want to invest where I do, just go ahead and text family to six, 686, six. Role under this specific expert with income property, you need Ridge Lending Group and MLS for 256 injury history from beginners to veterans. They provided our listeners with more mortgages than anyone. It's where I get my own loans for single family rentals up to four Plex's. Start your pre-qualification and chat with President Charlie Ridge personally. They'll even customize a plan tailored to you for growing your portfolio. Start at Ridge Lending group.com Ridge lending group.com.   Speaker 5 (00:23:49) - This is the Real World Network's Cathy Fekete, and you are listening to the always valuable get Rich education with Keith Reinhold.   Keith Weinhold (00:24:06) - You're listening to the SOS created more financial freedom for busy people just like you than nearly any show in the world. This is guitarist education. I'm your host, Keith Whitehill. We're talking with ECI development chairman and CEO Mike Cobb about teak hardwood investing in Panama and Nicaragua.   Keith Weinhold (00:24:22) - Like, tell us more about how one can achieve residency, for example, in Panama if they own teak there maybe just how residency varies from citizenship?   Michael Cobb (00:24:33) - Sure. Well, why don't we start with the second part, how residency differs from citizenship. And there's a good place to start. You know, citizenship is you become a citizen of the country. You have a passport, you can vote. You have every legal right of that country. Right. The decision would have residency to use a US term is like a green card, right? It's the legal permission to live in that country for some period of time. Many of them are permanent. In fact, Panama's is permanent. So once you have a Panama permanent residency, you could literally pick up, you could move there tomorrow, and you could live for the rest of your life in Panama. And so it gives you the legal right to live there. But you don't have a passport. You can't vote. I guess that's the main difference, right? You don't have a passport, you can't vote.   Michael Cobb (00:25:18) - But for most people, in fact, the overwhelming majority of people, a residency delivers exactly what somebody wants, which is the ability to live somewhere. Right? And we don't care if we vote or not. I mean, right, we'd still be citizens of our home country, US, Canada, or wherever we can vote back home or citizen. We have our passport from those countries, but the right to live somewhere else is powerful. And so the teak in Panama qualifies you in two ways for two quarter acre parcels, and then the legal fees and stuff like that. It's just under 22,000. A little less gives you permanent residency in Panama. Right? That's such an affordable way to be able to I call it the back pocket. Right. The insurance policy or the plan B in the sense that, like, I think a lot of folks are worried about the direction things are headed. And, you know, you have the teak parcels, which are going to produce a tremendous return. And then this byproduct that you qualify for and you have to go, you have to get down there a couple times.   Michael Cobb (00:26:16) - I mean, there's a little bit of administrative stuff, some legal fees, that's all included in that 22,000. Right. So that's all included. You have to go there a couple times. So there's a little bit of friction I would say. But when you get finished with that friction, you are a permanent resident of Panama and you only have to go there one day every two years. So you fly down every other year, whatever. Go, go talk to your trees, maybe sing to your trees a little bit, whatever you want to do and fly. All right. And you have a permanent residency. So it's a very easy, fast way to get that plan B now in the future, if you ever said, well, I really love Panama, I'd like to live here. Panama is beautiful. The city itself, it's got skyscrapers, apartments on the 50th floor of use or killer. You can be out on the beach or somewhere. You can be up in the mountains. So there are a lot of different climates and geographies in Panama where you might say to yourself, yeah, I think I want to come down here and live someday.   Michael Cobb (00:27:09) - Well, you already have your residency. You already have the legal right to do that.   Keith Weinhold (00:27:14) - Yeah, I mean, 100%. Now, Panama isn't predominantly English speaking like Belize is, but Panama just has a lot of inherent familiarity and feel to a lot of Americans. Since the canal is there and there is that strong American presence, and they've even dollarization their economy there, for example, in Panama. So it might be that nice plan B for you. And tell us more about the residency and the investment into the sawmill and how that works. So it sounds like there's now a value added component is you essentially vertically integrated and now have this sawmill with the teeth. Tell us more about that.   Michael Cobb (00:27:56) - So we've always factored in the sawmill into the investment proposition. Because if we were to just take the logs for example, 25 years, you cut down the trees, you stick the logs in the container and send them off to China or India, which is where most of the logs go. The return on investments.   Michael Cobb (00:28:13) - It's not great, it's okay, but it's not great. The way you actually get a phenomenal return on investment is you take those logs and you turn them into lumber, which has about a 3 to 4 x differential, or what we call first stage end product or simple end product, which would be something like flooring, which is basically lumber that's been finished one more level rooted and bulldozed so that you can put them together right on a wood floor. So those two modifications from the log all the way to the first degree of finished product, the returns start to really jack it up into that double digit IRR right over 25 years, which again is phenomenal. So we talked about price. But just to give an idea, a $7,000 quarter acre parcel at harvest turned into lumber and first level finished. Product turns into about $94,000, right? So 7000 turns into $90,000, which is a tremendous return. But the way you get that return is to deliver to the marketplace lumber and first grade finished product. And so Soma has always been part of our business plan.   Michael Cobb (00:29:19) - Well, we are now two years away from our harvest on our first plantation, the one I planted back in 1999. Right? I mean, it's incredible thinking that, you know, 20, gosh, 24 years ago planted a teak plantation. So we're two years from harvest. We have one more set of kind of odds and end thinning of just trees that didn't quite grow. Right. We're going to use those thinning over the next couple of years to practice in our sawmill. Because you know what? We are going to make mistakes. I mean, you don't ever get it right the first time. So we're going to make mistakes. We're going to learn from them. And by the time we actually do the real harvest of that first plantation, 100 acres of teak, two years from now, we will be up to speed with our sawmill will size up, we'll capacity up to do that. But yeah, so folks can actually we have a $2 million opening in the sawmill. And it's a real simple formula.   Michael Cobb (00:30:07) - It's two times your money and then a proportionate 10% interest in the sawmill. So for example, just rough numbers off the top of my head. You put in $100,000, you get twice your money back in about a 3 to 4 year period. As a sawmill really becomes operational. We take the first harvest, like the thinning, aren't going to produce much. In fact, we hope to just basically kind of break even over the next two years while we practice. Then we cut down 100 acres of teak. We start putting that through the sawmill, right? So you get two extra money, you invest 100 to get back to 100, and then your return would be about 13 or $14,000 a year. On going after that, because you get a 10% carried interest in the sawmill into the future as well. So that's the investment opportunity that produces a shorter cash flow, much tighter on the cash flow. But then a nice trailer for many years. But the investment is 100,000. So it's a more significant investment than, say, somebody wanting a little bite sized piece of a quarter acre parcel or two quarter acre type parcels paired with the residency that gets you that.   Michael Cobb (00:31:13) - So a couple different levels of investment depending on what your goals are, but also what your timelines are.   Keith Weinhold (00:31:19) - We described the sawmill investment numbers there. And then just to clarify, on the quarter acre parcels, they cost $7,000 each with an expected value or return of $94,000 after 25 years.   Michael Cobb (00:31:37) - That's correct. 6880. I'm using round numbers, but 6880 is the quarter acre teak and right at harvest when it processes through the sawmill. A little over that, but $94,000 is returned to the investor along the way. I'll mention this. There are maintenance fees. It's about $150 a year. We just take a credit card. We just tap it once a year. That takes care of property taxes, thinning, cleaning, anything that they have to do with the plantation. So $150 a year, your maintenance fee. But yeah, 6880 turns into 94,025 years. If teak continues to go up at 5.5% a year, the return would be better than that.   Keith Weinhold (00:32:16) - You probably have investors that come in oftentimes from North America, maybe some from Europe, and they see this as a really low cost of entry, $6,880 for one quarter acre parcel.   Keith Weinhold (00:32:29) - So are there any risks that one should consider? Therefore, if they're a first time investor abroad, maybe something they're not thinking about if they buy a rental single family home in their own hometown?   Michael Cobb (00:32:41) - Yeah. Very different. I mean, in some ways it's very different. In other ways it's pretty similar. Right. You're going to get title to the property. The process of getting title will be a little different. You're going to have to send in copies of your passport, a notarized utility bill. Just some things that you wouldn't have to do if you were buying a property in the States. But at the end of the day, you will get what's called Escritorio Publica public title. So it's a registered land deed. And so that part of it's all pretty similar risk factors. Absolutely. The business plan has them in there. But the big ones are any kind of disease. It's monoculture. So I mean a disease could come through and kill all the trees. Right. The good thing there is, again, teak has a 350 year track record of being managed and grown in plantations.   Michael Cobb (00:33:24) - So it has a long track record where they've kind of figured out, well, if this happens, then do this or if this pest comes along. This is how we, you know, we mitigate that, but nothing can mitigate all risk. That fire is an interesting one. Fire is a risk in the first three years of teak. So we call it baby teak. But once the tea trees are 3 to 4 years old, they're really above any kind of fire. Because you clean the plantation and the guys are in there with the machetes chopping to keep the, you know, the brushed and grass down in the dry season, which, by the way, you mention the qualities of teak, the hardness of teak is actually the most. Prized quality. And so the hardest of the teak that we get will actually be taken and sold as marine lumber, which is an unbelievable differential in price. But only 5 to 10% of your teak would qualify as marine lumber. So it's a small percentage, but the value of that is very, very high because it's set to hardwood.   Michael Cobb (00:34:20) - But the rest of the tree is also likewise very hard. The dry season is what cures the teak. And so in the dry season teak drops its leaves. And so it's very resistant to fire. If you do good maintenance on the plantation, we do so fires only a risk really in the first three years. And we actually warranty the trees of a fire comes through. In the first three years. We replant the plantation for any parts that are burned. So there's sort of a warranty that comes with the first three years. I mean, the other risks are political risk. What if Panama goes off the rails? The good thing about Panama, it's got the canal. And that is a major, vital strategic US interest. I just don't see the US letting Panama kind of go off the rails. But it could. But those I think are the three what I would call main risk factors. And we mitigate those to the best way possible.   Keith Weinhold (00:35:13) - You heard Mike mention about the thinning and cleaning. Yes, there is ongoing management, but that is already handled and taken care of in any of the prices that you already mentioned.   Keith Weinhold (00:35:24) - Is that right, Mike?   Michael Cobb (00:35:25) - Yeah, correct. And we outsource to a company called Geo Forest. All Geo Forest, all. They've been our plantation manager from since 1999. And and they're phenomenal. What they do, their world class. They've been doing it for longer than 25 years, maybe 30 years at this point. But we outsource what we have to outsource because we're not management plantation managers. So we can find folks that are.   Keith Weinhold (00:35:47) - The same property manager for a quarter century, a property manager that actually doesn't get fired. Hey, that's a novel concept. Two times two is what some investors back here in the U.S. are thinking with their residential real estate investments. If you want to learn more about this investment, I encourage you to check it out. You can do that through Gray Marketplace at Gray marketplace.com/teak. Mike, do you still offer tours.   Michael Cobb (00:36:16) - Oh my goodness yes. And I hope that you will take us up on the opportunity to come down and see the dairy and province. But yes, we do.   Michael Cobb (00:36:24) - And I don't know the dates off the top of my head, but for folks who are interested, uh, two things. One, we actually run a tour that's fun because it's a group of people and it's just, you know, you come down and you do it. But if somebody says, hey, I can't make those dates, but I want to come see the trees. Yeah, it's very reasonable. I think it's a couple hundred bucks. They pick you up at your hotel, they'll run you out to the plantation, bring you back. But it's a whole day. I mean, it's four hours outside of Panama City and four hours back, so it's a long day. And if it's a couple, it's still 200. It's basically for the vehicle out and back. Right? The driver and the vehicle. So you can come anytime or you can come with a group. And if you come with a group there is no charge. I mean, we get the van or the bus and we pay for it all.   Michael Cobb (00:37:03) - And yeah, we make peanut butter and jelly sandwiches and we have fun.   Keith Weinhold (00:37:07) - All right. Well, I think people have probably covered for the tea more than the sandwiches, but that is a nice touch that you do for people because you do that whether someone is a great investor or not, whether they haven't invested at all yet, and they just want to go ahead and check it out. And you can learn more about those dates at GR marketplace.com/teague Mike, it's always such a fun chat to discuss something so exotic. It's been great having you back on the show.   Michael Cobb (00:37:34) - Nice to be back with you. I look forward to seeing you in Panama one of these days.   Keith Weinhold (00:37:43) - Trees grow through recessions, they grow through market cycles, they grow through Covid, and trees just keep growing through every single fed rate decision. The wealthiest families on the planet, the top 1%. They have locked up vast portions of their wealth for timeframes even longer than the 25 year peak harvest cycle. In fact, Harvard has fully 10% of its endowment, specifically in timber.   Keith Weinhold (00:38:11) - To follow up on what I asked earlier, as we're discussing non-residential real estate today, Earth's highest point above sea level is Mount Everest. The highest from base to peak is Monica. But Earth's highest piece of land, uh, the highest point is measured from the center of the Earth is Chimborazo Volcano, Ecuador. That's because Earth is not a perfect sphere. But there's an equatorial bulge. That's what I was climbing ten days ago. Earth's highest real estate, Chimborazo, was also there for the closest real estate to the sun and moon. But back down here at a lower elevation where the teak plantations are in Panama and Nicaragua, there are no loans for teak. But at prices under seven K, many GRI listeners have found that they don't need a loan and they have bought ten or more parcels. But you can buy as few as 1 or 2 a quarter acre teak parcels and then later cash it out for yourself or build that wealth legacy for your family. Kind of like the top 1%. If it sounds interesting to you, learn more.   Keith Weinhold (00:39:22) - Get started at GR marketplace.com/t. Until next week. I'm your host, Keith Wild. Don't quit your day dream.   Speaker 6 (00:39:34) - Nothing on this show should be considered specific, personal or professional advice. Please consult an appropriate tax, legal, real estate, financial or business professional for individualized advice. Opinions of guests are their own. Information is not guaranteed. All investment strategies have the potential for profit or loss. The host is operating on behalf of get Rich education LLC exclusively. The.   Keith Weinhold (00:40:02) - The preceding program was brought to you by your home for wealth building. Get rich education.com.

Creating a software company by integrating several systems is not a new concept. Private equity has done it time and time again. But who would have thought of creating another Infor or ECi when music has completely stopped for the private equity industry? Is the strategy successful? Maybe? Maybe not? While the strategy might be successful in the large market segment, the smaller products were created because of frustration with their larger peers. Also, the only reason mom-and-pop ERP vendors were successful is because they were willing to put in the sweat equity that none of the larger companies would. So, how can private equity companies be successful in the smaller segment by simply changing the branding and providing an integrated experience? And where does Advantive stand in its capabilities, and how does it compare with other ERP, WMS, and MES vendors?In today's episode, we invited a panel of industry experts for a live discussion on LinkedIn to conduct an independent review of Advantive capabilities. We covered many grounds, including their evolution and roots as well as their corporate strategy. Finally, we covered different products and acquisitions in their portfolio and their unique strengths.For more information on growth strategies for SMBs using ERP and digital transformation, visit our community at wbs. rocks or elevatiq.com. To ensure that you never miss an episode of the WBS podcast, subscribe on your favorite podcasting platform. 

US equities ended lower Wednesday at worst levels after the latest FOMC announcement came in more hawkish than anticipated, with the Dow Jones, S&P500, and Nasdaq closing down 82bps, 161bps, and 223bps respectively. Post-earnings weakness in big tech the big story. FOMC statement removed tightening bias, as was widely expected, and noted employment and inflation moving into better balance. January ADP private payrolls missed. ECI was a bit weaker than consensus as well.

Today's Flash Back Friday Episode is from Episode #357, which originally aired on November 15, 2021. Michael Cobb is a real estate expert and international developer. After success in the computer industry, Michael formed ECI Development in 1996. This residential resort development company builds communities in Belize, Nicaragua, Costa Rica, Panama, El Salvador, and Mexico. Tropical neighborhoods include homes, condominiums, golf courses, and hotels in beach, agricultural, and mountain locations. Michael serves on the board of several multinational companies, charitable foundations, holds a CIPS certification, is a past International Director for NAR, and heads the International Referral Network (IRN) for Realtors. Michael and his wife, Carol, lived as expats, raising two daughters overseas, from 2002 through 2016.   Quote: “We started a mortgage company to provide financing to North Americans.. and that business ultimately grew into a bank, but we are still largely a mortgage company.” “Understanding that thin slicing of the marketplace is really important but also [is] understanding your goals and objectives.” “To me, the biggest form of asset protection is diversification, and not just in terms of asset classes.”   Highlights: 02:00 - Michael tells listeners more about life with his family in Nicaragua, culture shock, and raising children outside of him and his wife's native country. 07:24  - Michael discusses his shift from the technology industry into the real estate world and how ECI Development came to be. 12:54 - Michael tells us the reasons why his company doesn't have many competitors. 15:23 - Michael lists some reasons why Central American real estate is so appealing. 28:50  - Michael talks about asset protection when owning real estate in Central America. 34:21 -  Michael touches on ECI's current real estate developments. 40:23 - Michael describes the process of someone touring properties.   Guest Website: https://www.ecidevelopment.com/   Recommended Resources:  Accredited Investors, you're invited to Join the Cashflow Investor Club to learn how you can partner with Kevin Bupp on current and upcoming opportunities to create passive cash flow and build wealth. Join the Club! If you're a high net worth investor with capital to deploy in the next 12 months and you want to build passive income and wealth with a trusted partner, go to InvestWithKB.com for opportunities to invest in real estate projects alongside Kevin and his team.  Looking for the ultimate guide to passive investing? Grab a copy of my latest book, The Cash Flow Investor at KevinBupp.com.  Tap into a wealth of free information on Commercial Real Estate Investing by listening to past podcast episodes at KevinBupp.com/Podcast. Learn more about Kevin's investment company and opportunities for Lifetime Cashflow at sunrisecapitalinvestors.com.